Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 62 | 0 | 0 | 62 |
thioredoxin reductase | 68 | 0 | 0 | 68 |
ATAD5 protein, partial | 34 | 0 | 0 | 34 |
GLS protein | 43 | 0 | 0 | 43 |
TDP1 protein | 120 | 0 | 0 | 120 |
regulator of G-protein signaling 4 | 34 | 0 | 0 | 34 |
67.9K protein | 35 | 0 | 0 | 35 |
Parkin | 11 | 0 | 0 | 11 |
bromodomain adjacent to zinc finger domain 2B | 19 | 0 | 0 | 19 |
IDH1 | 43 | 0 | 0 | 43 |
euchromatic histone-lysine N-methyltransferase 2 | 96 | 0 | 0 | 96 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 37 | 0 | 0 | 37 |
huntingtin isoform 2 | 8 | 0 | 0 | 8 |
ras-related protein Rab-9A | 15 | 0 | 0 | 15 |
serine/threonine-protein kinase mTOR isoform 1 | 15 | 0 | 0 | 15 |
urokinase-type plasminogen activator precursor | 27 | 0 | 0 | 27 |
plasminogen precursor | 27 | 0 | 0 | 27 |
urokinase plasminogen activator surface receptor precursor | 27 | 0 | 0 | 27 |
survival motor neuron protein isoform d | 39 | 0 | 0 | 39 |
D(1A) dopamine receptor | 4 | 1 | 0 | 5 |
Ataxin-2 | 50 | 0 | 0 | 50 |
ATP-dependent phosphofructokinase | 37 | 0 | 0 | 37 |
Chain A, Cruzipain | 23 | 0 | 0 | 23 |
Platelet-activating factor receptor | 1 | 3 | 0 | 4 |
Inositol monophosphatase 1 | 12 | 0 | 0 | 12 |
Chain A, High-affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, Phosphodiesterase 9A | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 20 | 0 | 0 | 20 |
Chain A, Class I phosphodiesterase PDEB1 | 0 | 1 | 0 | 1 |
Chain A, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
Chain A, cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera | 0 | 1 | 0 | 1 |
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 28 | 0 | 0 | 28 |
thyroid stimulating hormone receptor | 43 | 0 | 0 | 43 |
estrogen-related nuclear receptor alpha | 109 | 0 | 0 | 109 |
Phosphodiesterase | 0 | 3 | 0 | 3 |
mitogen-activated protein kinase 1 | 27 | 0 | 0 | 27 |
geminin | 111 | 0 | 0 | 111 |
cytochrome P450 3A4 isoform 1 | 52 | 0 | 0 | 52 |
histone acetyltransferase KAT2A isoform 1 | 34 | 0 | 0 | 34 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit pi | 52 | 4 | 5 | 61 |
Monocarboxylate transporter 4 | 0 | 2 | 0 | 3 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 3 | 0 | 3 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 7 | 0 | 8 |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 2 | 0 | 2 |
Renin | 0 | 6 | 0 | 6 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 3 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 5 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 4 | 0 | 5 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-1 | 52 | 4 | 5 | 61 |
Gamma-aminobutyric acid receptor subunit delta | 52 | 4 | 5 | 61 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 52 | 4 | 5 | 61 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 52 | 4 | 5 | 61 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 52 | 4 | 5 | 61 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 52 | 5 | 5 | 62 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 52 | 4 | 5 | 61 |
Adenosine receptor A1 | 0 | 13 | 0 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 52 | 4 | 5 | 61 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 52 | 4 | 5 | 61 |
Adenosine receptor A3 | 0 | 4 | 0 | 4 |
Adenosine receptor A2a | 0 | 7 | 5 | 15 |
Adenosine receptor A2b | 0 | 3 | 0 | 6 |
Adenosine receptor A2b | 0 | 6 | 2 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 52 | 4 | 5 | 61 |
Adenosine receptor A1 | 0 | 5 | 3 | 14 |
Adenosine receptor A2a | 0 | 11 | 2 | 19 |
Sodium-dependent serotonin transporter | 0 | 7 | 1 | 9 |
Adenosine receptor A2a | 0 | 3 | 0 | 3 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 4 | 0 | 5 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 52 | 6 | 5 | 63 |
Gamma-aminobutyric acid receptor subunit beta-3 | 52 | 4 | 5 | 61 |
Gamma-aminobutyric acid receptor subunit beta-2 | 52 | 4 | 5 | 61 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 3 | 0 | 3 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 4 | 0 | 5 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 3 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 8 | 1 | 9 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 8 | 1 | 10 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 4 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 9 | 0 | 9 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 4 | 0 | 4 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 4 | 0 | 5 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 5 | 0 | 6 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 3 | 0 | 3 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
GABA theta subunit | 52 | 4 | 5 | 61 |
Phosphodiesterase | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit epsilon | 52 | 4 | 5 | 61 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 2 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 33 | 0 | 0 | 33 |
RAR-related orphan receptor gamma | 89 | 0 | 0 | 89 |
GLI family zinc finger 3 | 88 | 0 | 0 | 88 |
AR protein | 128 | 0 | 0 | 128 |
estrogen receptor 2 (ER beta) | 48 | 0 | 0 | 48 |
nuclear receptor subfamily 1, group I, member 3 | 72 | 0 | 0 | 72 |
progesterone receptor | 65 | 0 | 0 | 65 |
retinoid X nuclear receptor alpha | 78 | 0 | 0 | 78 |
thyroid hormone receptor beta isoform 2 | 91 | 0 | 0 | 91 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 86 | 0 | 0 | 86 |
Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 36 | 0 | 0 | 36 |
aldehyde dehydrogenase 1 family, member A1 | 65 | 0 | 0 | 65 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 6 | 0 | 6 |
Guanine nucleotide-binding protein G | 14 | 0 | 0 | 14 |
TAR DNA-binding protein 43 | 27 | 0 | 0 | 27 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 1 | 3 |
Monocarboxylate transporter 1 | 0 | 1 | 0 | 2 |
Monocarboxylate transporter 2 | 0 | 2 | 0 | 2 |
retinoic acid nuclear receptor alpha variant 1 | 90 | 0 | 0 | 90 |
estrogen nuclear receptor alpha | 147 | 0 | 0 | 147 |
peroxisome proliferator-activated receptor delta | 54 | 0 | 0 | 54 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 71 | 0 | 0 | 71 |
activating transcription factor 6 | 35 | 0 | 0 | 35 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 39 | 0 | 0 | 39 |
Histone H2A.x | 37 | 0 | 0 | 37 |
thyroid hormone receptor beta isoform a | 36 | 0 | 0 | 36 |
heat shock protein beta-1 | 35 | 0 | 0 | 35 |
lamin isoform A-delta10 | 88 | 0 | 0 | 88 |
Voltage-dependent calcium channel gamma-2 subunit | 48 | 0 | 0 | 48 |
Glutamate receptor 2 | 49 | 1 | 0 | 50 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 19 | 0 | 0 | 19 |
phosphopantetheinyl transferase | 44 | 0 | 0 | 44 |
pyruvate kinase PKM isoform a | 3 | 0 | 0 | 3 |
Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
Tubulin--tyrosine ligase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 31 | 1 | 43 |
Carbonic anhydrase 2 | 0 | 32 | 4 | 46 |
Hepatocyte growth factor receptor | 0 | 2 | 5 | 7 |
Replicase polyprotein 1ab | 0 | 16 | 8 | 24 |
Carbonic anhydrase 5A, mitochondrial | 0 | 12 | 2 | 22 |
Carbonic anhydrase | 0 | 6 | 0 | 6 |
Beta-carbonic anhydrase 1 | 0 | 7 | 0 | 7 |
Carbonic anhydrase | 0 | 6 | 0 | 9 |
Carbonic anhydrase | 0 | 6 | 0 | 10 |
Carbonic anhydrase 5B, mitochondrial | 0 | 10 | 1 | 19 |
Microtubule-associated protein tau | 49 | 0 | 0 | 49 |
Smad3 | 27 | 0 | 0 | 27 |
EWS/FLI fusion protein | 63 | 0 | 0 | 64 |
peroxisome proliferator activated receptor gamma | 67 | 0 | 0 | 67 |
aryl hydrocarbon receptor | 50 | 0 | 0 | 50 |
chromobox protein homolog 1 | 62 | 0 | 0 | 62 |
peripheral myelin protein 22 | 52 | 0 | 0 | 52 |
ATP-binding cassette sub-family C member 3 | 0 | 88 | 0 | 88 |
Multidrug resistance-associated protein 4 | 0 | 88 | 0 | 92 |
Solute carrier family 22 member 6 | 0 | 19 | 0 | 22 |
Carbonic anhydrase 12 | 0 | 13 | 1 | 21 |
UDP-glucuronosyltransferase 1A9 | 0 | 2 | 0 | 6 |
Bile salt export pump | 0 | 22 | 0 | 22 |
Bile salt export pump | 0 | 125 | 0 | 125 |
Cytochrome P450 2B1 | 0 | 1 | 0 | 2 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 2 | 1 | 4 |
Cytochrome P450 1A2 | 0 | 13 | 2 | 16 |
Prostaglandin G/H synthase 1 | 0 | 24 | 0 | 25 |
Carbonic anhydrase 3 | 0 | 9 | 1 | 16 |
Cytochrome P450 3A4 | 0 | 39 | 2 | 46 |
Cytochrome P450 2D6 | 0 | 26 | 2 | 28 |
Cytochrome P450 2C9 | 0 | 39 | 2 | 43 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 4 | 0 | 4 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 4 | 0 | 6 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A1 | 0 | 7 | 0 | 9 |
Carbonic anhydrase 4 | 0 | 17 | 1 | 24 |
Prostaglandin G/H synthase 1 | 0 | 23 | 0 | 24 |
Carbonic anhydrase 6 | 0 | 10 | 1 | 17 |
Prostaglandin G/H synthase 2 | 0 | 29 | 4 | 36 |
Carbonic anhydrase 7 | 0 | 11 | 1 | 18 |
Nuclear receptor ROR-gamma | 23 | 1 | 1 | 25 |
Cytochrome P450 2J2 | 0 | 18 | 0 | 18 |
Carbonic anhydrase 9 | 0 | 18 | 1 | 26 |
Canalicular multispecific organic anion transporter 1 | 0 | 85 | 0 | 85 |
Carbonic anhydrase 15 | 0 | 10 | 0 | 13 |
Carbonic anhydrase 13 | 0 | 7 | 0 | 12 |
Carbonic anhydrase 14 | 0 | 10 | 1 | 18 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 27 | 0 | 0 | 27 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Carbonic anhydrase | 0 | 5 | 0 | 5 |
GALC protein | 9 | 0 | 0 | 9 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 76 | 0 | 0 | 76 |
glucocorticoid receptor [Homo sapiens] | 104 | 0 | 0 | 104 |
Carbonic anhydrase | 0 | 5 | 0 | 5 |
Carbonic anhydrase | 0 | 6 | 0 | 6 |
arylsulfatase A | 35 | 0 | 0 | 35 |
Carbonic anhydrase | 0 | 6 | 0 | 6 |
Bloom syndrome protein isoform 1 | 32 | 0 | 0 | 32 |
muscleblind-like protein 1 isoform 1 | 18 | 0 | 0 | 18 |
Carbonic anhydrase | 0 | 4 | 0 | 4 |
Prolyl endopeptidase | 0 | 3 | 0 | 3 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 3 |
Glycogen phosphorylase, muscle form | 0 | 5 | 0 | 5 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cathepsin B | 0 | 2 | 0 | 2 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 7 | 0 | 8 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 7 | 1 | 8 |
Cytochrome P450 2C8 | 0 | 6 | 0 | 8 |
Cytochrome P450 2A6 | 0 | 5 | 1 | 6 |
5-hydroxytryptamine receptor 2A | 0 | 10 | 0 | 10 |
Androgen receptor | 0 | 17 | 0 | 17 |
Translocator protein | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 4 | 2 | 8 |
Carbonic anhydrase 5A, mitochondrial | 0 | 4 | 0 | 4 |
Serum paraoxonase/arylesterase 1 | 0 | 5 | 0 | 5 |
Dipeptidyl peptidase 4 | 0 | 6 | 0 | 8 |
Endochitinase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 7 | 0 | 7 |
Delta-type opioid receptor | 0 | 7 | 0 | 7 |
Cytochrome P450 2C19 | 0 | 16 | 1 | 18 |
Delta-type opioid receptor | 0 | 7 | 0 | 7 |
Mu-type opioid receptor | 0 | 7 | 0 | 7 |
Carbonic anhydrase | 0 | 9 | 0 | 11 |
Kappa-type opioid receptor | 0 | 3 | 0 | 6 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 5 | 0 | 8 |
D(2) dopamine receptor | 0 | 9 | 2 | 12 |
Cholinesterase | 0 | 7 | 0 | 7 |
Mu-type opioid receptor | 0 | 9 | 0 | 9 |
Fatty-acid amide hydrolase 1 | 0 | 7 | 0 | 7 |
Carbonic anhydrase 2 | 0 | 5 | 0 | 5 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 7 | 1 | 10 |
Squalene synthase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 6 | 0 | 6 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 6 | 0 | 10 |
Carbonic anhydrase | 0 | 5 | 0 | 5 |
Sigma intracellular receptor 2 | 0 | 5 | 0 | 5 |
Delta carbonic anhydrase | 0 | 5 | 0 | 5 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 5 | 0 | 8 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 8 | 1 | 11 |
Carbonic anhydrase 4 | 0 | 11 | 0 | 12 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 35 | 0 | 0 | 35 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 17 | 0 | 0 | 17 |
acetylcholinesterase | 27 | 0 | 0 | 27 |
dopamine D1 receptor | 11 | 0 | 0 | 11 |
15-lipoxygenase, partial | 17 | 0 | 0 | 17 |
pregnane X receptor | 20 | 0 | 0 | 20 |
USP1 protein, partial | 52 | 0 | 0 | 52 |
NFKB1 protein, partial | 17 | 0 | 0 | 17 |
Thrombopoietin | 9 | 0 | 0 | 9 |
farnesoid X nuclear receptor | 57 | 0 | 0 | 57 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 67 | 0 | 0 | 67 |
D(1A) dopamine receptor | 13 | 0 | 0 | 13 |
flap endonuclease 1 | 26 | 0 | 0 | 26 |
muscarinic acetylcholine receptor M1 | 23 | 0 | 0 | 23 |
Histone deacetylase 3 | 0 | 11 | 0 | 11 |
Histone deacetylase 4 | 0 | 9 | 0 | 9 |
Histone deacetylase 1 | 0 | 12 | 0 | 12 |
Histone deacetylase 7 | 0 | 9 | 0 | 9 |
Histone deacetylase 2 | 0 | 12 | 0 | 12 |
Polyamine deacetylase HDAC10 | 0 | 8 | 0 | 8 |
Histone deacetylase 11 | 0 | 9 | 0 | 9 |
Histone deacetylase 8 | 0 | 11 | 0 | 11 |
Histone deacetylase 6 | 0 | 10 | 0 | 10 |
Histone deacetylase 9 | 0 | 8 | 0 | 8 |
Histone deacetylase 5 | 0 | 9 | 0 | 9 |
Chain A, Ferritin light chain | 23 | 0 | 0 | 23 |
alpha-galactosidase | 12 | 0 | 0 | 12 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 32 | 0 | 0 | 32 |
DNA polymerase iota isoform a (long) | 40 | 0 | 0 | 40 |
DNA topoisomerase 2-alpha | 0 | 1 | 6 | 13 |
Acetylcholinesterase | 0 | 12 | 0 | 12 |
Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 31 | 0 | 0 | 31 |
Chain B, HADH2 protein | 31 | 0 | 0 | 31 |
Thymidine kinase | 0 | 7 | 0 | 8 |
hemoglobin subunit beta | 7 | 0 | 0 | 7 |
atrial natriuretic peptide receptor 1 precursor | 6 | 0 | 0 | 6 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 13 | 0 | 0 | 13 |
Solute carrier family 22 member 1 | 0 | 15 | 0 | 22 |
Purine nucleoside phosphorylase | 0 | 3 | 0 | 3 |
Thymidine kinase, cytosolic | 0 | 8 | 0 | 13 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 2 |
Disintegrin and metalloproteinase domain-containing protein 17 | 10 | 1 | 0 | 11 |
Purine nucleoside phosphorylase | 0 | 0 | 4 | 4 |
Solute carrier family 22 member 6 | 0 | 18 | 0 | 27 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 15 | 0 | 24 |
Thymidine kinase | 0 | 3 | 0 | 4 |
Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
pregnane X nuclear receptor | 89 | 0 | 0 | 89 |
importin subunit beta-1 isoform 1 | 14 | 0 | 0 | 14 |
snurportin-1 | 14 | 0 | 0 | 14 |
tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 8 | 0 | 0 | 8 |
Cyclin-dependent kinase 1 | 0 | 3 | 6 | 9 |
Heat shock protein HSP 90-beta | 0 | 3 | 2 | 7 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 1 | 3 |
ATPase family AAA domain-containing protein 5 | 39 | 0 | 0 | 39 |
Fructose-1,6-bisphosphatase 1 | 0 | 2 | 0 | 3 |
Bifunctional purine biosynthesis protein ATIC | 0 | 4 | 0 | 5 |
Histidine triad nucleotide-binding protein 1 | 0 | 0 | 1 | 1 |
Luciferase | 50 | 0 | 0 | 50 |
Fumarate hydratase | 30 | 0 | 0 | 30 |
caspase 7, apoptosis-related cysteine protease | 14 | 0 | 0 | 14 |
polyprotein | 30 | 0 | 0 | 30 |
caspase-3 | 14 | 0 | 0 | 14 |
nuclear receptor subfamily 1, group I, member 2 | 29 | 0 | 0 | 29 |
cellular tumor antigen p53 isoform a | 20 | 0 | 0 | 20 |
transcriptional regulator ERG isoform 3 | 12 | 0 | 0 | 12 |
histone deacetylase 9 isoform 3 | 14 | 0 | 0 | 14 |
Vif | 0 | 0 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 6 | 0 | 0 | 6 |
neuropeptide S receptor isoform A | 13 | 0 | 0 | 13 |
Interferon beta | 75 | 0 | 0 | 75 |
Cellular tumor antigen p53 | 82 | 0 | 0 | 82 |
Integrin beta-3 | 13 | 1 | 0 | 14 |
Integrin alpha-IIb | 13 | 1 | 0 | 14 |
Methionine aminopeptidase | 0 | 2 | 0 | 2 |
Chain A, farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Geranylgeranyl pyrophosphate synthase | 0 | 4 | 0 | 5 |
Farnesyl pyrophosphate synthase | 0 | 6 | 0 | 6 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Farnesyl pyrophosphate synthase | 0 | 4 | 0 | 4 |
Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
interleukin 8 | 23 | 0 | 0 | 23 |
Polyphenol oxidase 2 | 0 | 3 | 0 | 4 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 3 |
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 4 | 1 | 6 |
Shiga toxin subunit A | 0 | 2 | 0 | 2 |
Histamine H3 receptor | 0 | 2 | 0 | 4 |
Thromboxane-A synthase | 0 | 7 | 0 | 7 |
Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 0 | 3 |
Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 0 | 3 |
Prostacyclin receptor | 0 | 5 | 2 | 7 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 3 | 3 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 6 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 6 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 2 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 2 |
apical membrane antigen 1, AMA1 | 11 | 0 | 0 | 11 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 2 |
Glutaminyl-peptide cyclotransferase | 0 | 2 | 0 | 2 |
Guanine deaminase | 0 | 3 | 0 | 4 |
G | 53 | 0 | 0 | 53 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 34 | 0 | 0 | 34 |
HLA class I histocompatibility antigen, B alpha chain | 53 | 0 | 0 | 53 |
Nicotinate phosphoribosyltransferase | 0 | 6 | 0 | 6 |
Inositol hexakisphosphate kinase 1 | 53 | 0 | 0 | 53 |
cytochrome P450 2C9, partial | 53 | 0 | 0 | 53 |
ORF73 | 0 | 0 | 2 | 2 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 47 | 0 | 0 | 47 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 26 | 0 | 28 |
Aurora kinase B | 0 | 3 | 6 | 9 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 12 | 0 | 13 |
Alpha-2A adrenergic receptor | 0 | 27 | 6 | 34 |
Alpha-2B adrenergic receptor | 0 | 26 | 4 | 31 |
Alpha-2C adrenergic receptor | 0 | 20 | 5 | 26 |
Alpha-2B adrenergic receptor | 0 | 14 | 3 | 17 |
Alpha-1D adrenergic receptor | 0 | 15 | 4 | 20 |
Alpha-1A adrenergic receptor | 0 | 5 | 6 | 12 |
Alpha-1B adrenergic receptor | 0 | 4 | 5 | 10 |
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
thioredoxin glutathione reductase | 19 | 0 | 0 | 19 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 8 | 0 | 0 | 8 |
nuclear receptor ROR-gamma isoform 1 | 34 | 0 | 0 | 34 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 4 | 0 | 0 | 4 |
DNA polymerase kappa isoform 1 | 30 | 0 | 0 | 30 |
caspase-1 isoform alpha precursor | 7 | 0 | 0 | 7 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 12 | 1 | 0 | 13 |
Prostaglandin G/H synthase 1 | 0 | 9 | 0 | 11 |
Trypsin | 0 | 2 | 0 | 3 |
Coagulation factor VII | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 5 | 0 | 5 |
60 kDa heat shock protein, mitochondrial | 0 | 7 | 0 | 7 |
Aromatase | 0 | 6 | 0 | 6 |
Tissue factor | 0 | 5 | 0 | 5 |
Fatty acid-binding protein, adipocyte | 0 | 1 | 1 | 2 |
Histamine H2 receptor | 27 | 2 | 3 | 33 |
10 kDa heat shock protein, mitochondrial | 0 | 7 | 0 | 7 |
Calmodulin | 0 | 1 | 1 | 3 |
Prostaglandin G/H synthase 2 | 0 | 11 | 0 | 12 |
Fatty acid-binding protein 5 | 0 | 2 | 0 | 2 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Thiosulfate sulfurtransferase | 0 | 7 | 0 | 7 |
Lanosterol 14-alpha demethylase | 0 | 5 | 1 | 6 |
60 kDa chaperonin | 0 | 7 | 0 | 7 |
10 kDa chaperonin | 0 | 7 | 0 | 7 |
Solute carrier organic anion transporter family member 1B3 | 0 | 15 | 0 | 18 |
Cytosolic phospholipase A2 gamma | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 15 | 0 | 18 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
cytochrome P450 2C19 precursor | 19 | 0 | 0 | 19 |
lethal factor (plasmid) | 25 | 0 | 0 | 25 |
Nitric oxide synthase, endothelial | 0 | 3 | 0 | 5 |
Nitric oxide synthase, brain | 0 | 7 | 0 | 8 |
Nitric oxide synthase, brain | 0 | 3 | 0 | 5 |
Nitric oxide synthase, inducible | 0 | 8 | 0 | 9 |
Nitric oxide synthase, inducible | 0 | 6 | 1 | 10 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 2 | 1 | 3 |
Urease | 0 | 3 | 0 | 4 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 2 | 0 | 2 |
Spike glycoprotein | 47 | 2 | 3 | 52 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 1 | 2 |
Egl nine homolog 1 | 0 | 0 | 1 | 2 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 1 | 2 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
GTP-binding protein (rab7) | 0 | 0 | 3 | 3 |
ras protein, partial | 0 | 0 | 3 | 3 |
hypothetical protein, conserved | 7 | 0 | 0 | 7 |
cytochrome P450 2D6 | 51 | 0 | 0 | 51 |
glucocerebrosidase | 10 | 0 | 0 | 10 |
Rac1 protein | 0 | 0 | 3 | 3 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 3 | 3 |
Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 7 | 0 | 8 |
Epidermal growth factor receptor | 0 | 19 | 8 | 28 |
Fatty acid-binding protein, liver | 0 | 6 | 0 | 6 |
Myeloperoxidase | 0 | 3 | 0 | 3 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 5 | 0 | 5 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 4 | 0 | 5 |
Urotensin-2 receptor | 0 | 2 | 0 | 2 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 2 | 0 | 2 |
Ras-related protein Rab-2A | 0 | 0 | 3 | 3 |
Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 5 | 0 | 5 |
Solute carrier family 22 member 6 | 0 | 5 | 0 | 5 |
Sigma non-opioid intracellular receptor 1 | 0 | 19 | 2 | 21 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 2 | 2 |
cystic fibrosis transmembrane conductance regulator | 0 | 2 | 0 | 2 |
DNA polymerase beta | 9 | 0 | 0 | 9 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 18 | 0 | 18 |
Muscarinic acetylcholine receptor M2 | 0 | 18 | 4 | 26 |
Muscarinic acetylcholine receptor M4 | 0 | 14 | 1 | 17 |
Muscarinic acetylcholine receptor M1 | 0 | 7 | 1 | 11 |
Muscarinic acetylcholine receptor M3 | 0 | 6 | 1 | 10 |
Muscarinic acetylcholine receptor M4 | 0 | 5 | 1 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 5 | 1 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 13 | 1 | 16 |
Muscarinic acetylcholine receptor M2 | 0 | 6 | 1 | 11 |
Muscarinic acetylcholine receptor M1 | 0 | 16 | 4 | 24 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 17 | 2 | 21 |
5-hydroxytryptamine receptor 2C | 0 | 18 | 2 | 20 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 6 | 0 | 6 |
Reverse transcriptase/RNaseH | 0 | 7 | 6 | 24 |
Muscarinic acetylcholine receptor | 0 | 1 | 2 | 4 |
SMAD family member 2 | 36 | 0 | 0 | 36 |
SMAD family member 3 | 36 | 0 | 0 | 36 |
P53 | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 32 | 0 | 0 | 32 |
peripheral myelin protein 22 isoform 1 | 15 | 0 | 0 | 15 |
M-phase phosphoprotein 8 | 13 | 0 | 0 | 13 |
Protein-arginine deiminase type-4 | 0 | 13 | 0 | 13 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
endonuclease IV | 10 | 0 | 0 | 10 |
BRCA1 | 3 | 0 | 0 | 3 |
WRN | 2 | 0 | 0 | 2 |
PPM1D protein | 24 | 0 | 0 | 24 |
Lysine-specific demethylase 4E | 0 | 2 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 5 | 4 | 9 |
cytochrome P450 2D6 isoform 1 | 21 | 0 | 0 | 21 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 6 | 0 | 0 | 6 |
cytochrome P450 2C9 precursor | 20 | 0 | 0 | 20 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 16 | 0 | 0 | 16 |
DNA polymerase eta isoform 1 | 7 | 0 | 0 | 7 |
dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 4 | 0 | 4 |
Lysine-specific histone demethylase 1A | 0 | 7 | 0 | 7 |
Rap guanine nucleotide exchange factor 3 | 11 | 0 | 0 | 11 |
Glucocorticoid receptor | 0 | 22 | 2 | 30 |
Progesterone receptor | 0 | 3 | 0 | 4 |
Trypsin-1 | 0 | 3 | 0 | 3 |
Trypsin-2 | 0 | 3 | 0 | 3 |
Tyrosine-protein kinase Yes | 0 | 2 | 6 | 8 |
ATP-dependent translocase ABCB1 | 0 | 24 | 1 | 32 |
Replicase polyprotein 1ab | 0 | 12 | 5 | 17 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 4 | 2 | 7 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 6 | 0 | 10 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Urease subunit alpha | 0 | 2 | 0 | 2 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
Cyclic AMP-responsive element-binding protein 1 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 4 | 0 | 4 |
Glutamate receptor 1 | 1 | 1 | 0 | 2 |
Glutamate receptor 3 | 1 | 1 | 0 | 2 |
Glutamate receptor 4 | 1 | 1 | 0 | 2 |
Casein kinase II subunit alpha' | 0 | 1 | 6 | 7 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 4 | 0 | 4 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 5 | 1 | 6 |
Trypsin-3 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 10 | 0 | 12 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 4 | 6 | 10 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
Alpha-synuclein | 9 | 7 | 1 | 17 |
Linoleate 9S-lipoxygenase-4 | 0 | 1 | 0 | 1 |
G protein-coupled receptor kinase 6 | 0 | 1 | 4 | 5 |
1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 4 | 0 | 4 |
Sodium- and chloride-dependent betaine transporter | 0 | 3 | 0 | 3 |
Prolyl endopeptidase | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 4 | 0 | 4 |
Serine/threonine-protein kinase PLK1 | 0 | 2 | 5 | 7 |
Death-associated protein kinase 1 | 0 | 1 | 1 | 2 |
Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
Casein kinase II subunit alpha | 0 | 1 | 1 | 2 |
Urease subunit beta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 4 | 0 | 4 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 6 | 0 | 6 |
Receptor-type tyrosine-protein phosphatase S | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 4 | 0 | 4 |
Cytochrome P450 1B1 | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 11 | 0 | 13 |
Integrase | 0 | 4 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 4 | 0 | 4 |
Casein kinase II subunit alpha 3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 4 | 0 | 4 |
Serine/threonine-protein kinase PLK3 | 0 | 1 | 1 | 2 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
Serine/threonine-protein kinase PLK2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 4 | 0 | 4 |
Sialidase-2 | 0 | 2 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 5 |
Nrf2 | 5 | 0 | 0 | 5 |
nonstructural protein 1 | 17 | 0 | 0 | 17 |
NPC intracellular cholesterol transporter 1 precursor | 5 | 0 | 0 | 5 |
potassium voltage-gated channel subfamily H member 2 isoform d | 24 | 0 | 0 | 24 |
atrial natriuretic peptide receptor 2 precursor | 4 | 0 | 0 | 4 |
transient receptor potential cation channel subfamily V member 1 | 2 | 0 | 0 | 2 |
Amyloid-beta precursor protein | 2 | 7 | 0 | 10 |
D(1A) dopamine receptor | 0 | 16 | 1 | 18 |
D(3) dopamine receptor | 0 | 20 | 0 | 21 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 32 | 0 | 0 | 32 |
Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 5 | 0 | 5 |
Neuraminidase | 0 | 3 | 0 | 3 |
Neuraminidase | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 9 | 0 | 9 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 7 | 0 | 7 |
Aldo-keto reductase family 1 member C3 | 0 | 8 | 0 | 8 |
Aldo-keto reductase family 1 member C2 | 0 | 5 | 0 | 5 |
core protein, partial | 0 | 1 | 0 | 1 |
Chain A, D-MALTODEXTRIN BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, Limit Dextrinase | 0 | 0 | 1 | 1 |
Chain A, Solute-binding protein | 0 | 0 | 1 | 1 |
Chain A, Solute-binding protein | 0 | 0 | 1 | 1 |
Chain B, SusD | 0 | 0 | 1 | 1 |
Chain A, SusD | 0 | 0 | 1 | 1 |
Chain A, SusD | 0 | 0 | 1 | 1 |
Chain A, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain B, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain C, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain D, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain E, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain F, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain G, Alpha-hemolysin | 0 | 0 | 1 | 1 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 20 | 0 | 20 |
Glycine receptor subunit beta | 0 | 20 | 0 | 20 |
Glycine receptor subunit alpha-2 | 0 | 20 | 0 | 20 |
Glycine receptor subunit alpha-3 | 0 | 20 | 0 | 20 |
Beta-1 adrenergic receptor | 0 | 1 | 6 | 9 |
hexokinase-4 isoform 1 | 4 | 0 | 0 | 4 |
glucokinase regulatory protein | 4 | 0 | 0 | 4 |
Beta-1 adrenergic receptor | 0 | 13 | 5 | 18 |
Beta-1 adrenergic receptor | 0 | 8 | 4 | 14 |
5-hydroxytryptamine receptor 1A | 0 | 24 | 5 | 31 |
Beta-2 adrenergic receptor | 0 | 1 | 2 | 3 |
Beta-2 adrenergic receptor | 0 | 1 | 6 | 8 |
Chain H, Proteasome component PUP1 | 0 | 1 | 0 | 1 |
Chain I, Proteasome component PUP3 | 0 | 1 | 0 | 1 |
Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-11 | 0 | 1 | 0 | 2 |
Caspase-7 | 9 | 0 | 0 | 9 |
caspase-3 | 9 | 0 | 0 | 9 |
26S proteasome non-ATPase regulatory subunit 11 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 12 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 14 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-7 | 0 | 1 | 0 | 2 |
26S proteasome non-ATPase regulatory subunit 3 | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 4 | 0 | 4 |
Cathepsin B | 0 | 2 | 0 | 2 |
Neutrophil elastase | 0 | 3 | 0 | 3 |
Cathepsin G | 0 | 2 | 0 | 2 |
Lysosomal protective protein | 0 | 1 | 0 | 1 |
Chymotrypsinogen B | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 6A | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 3 | 0 | 3 |
Proteasome subunit beta type-1 | 0 | 1 | 0 | 3 |
Chymase | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-1 | 0 | 1 | 0 | 2 |
Proteasome subunit alpha type-2 | 0 | 1 | 0 | 2 |
Proteasome subunit alpha type-3 | 0 | 1 | 0 | 2 |
Proteasome subunit alpha type-4 | 0 | 1 | 0 | 2 |
Proteasome subunit beta type-8 | 0 | 1 | 0 | 2 |
Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 1 | 0 | 2 |
Proteasome subunit alpha type-5 | 0 | 1 | 0 | 2 |
Proteasome subunit beta type-4 | 0 | 1 | 0 | 2 |
Proteasome subunit beta type-6 | 0 | 1 | 0 | 2 |
Proteasome subunit beta type-5 | 0 | 4 | 0 | 6 |
26S proteasome regulatory subunit 7 | 0 | 1 | 0 | 1 |
Lon protease homolog, mitochondrial | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-10 | 0 | 1 | 0 | 2 |
26S proteasome regulatory subunit 6B | 0 | 1 | 6 | 7 |
26S proteasome non-ATPase regulatory subunit 8 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-3 | 0 | 1 | 0 | 2 |
Proteasome subunit beta type-2 | 0 | 1 | 0 | 3 |
26S proteasome non-ATPase regulatory subunit 7 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 4 | 0 | 1 | 0 | 1 |
26S proteasome complex subunit SEM1 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 1 | 1 | 3 |
26S proteasome regulatory subunit 4 | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 8 | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 10B | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p100 subunit | 0 | 3 | 0 | 3 |
Transcription factor p65 | 0 | 4 | 0 | 4 |
26S proteasome non-ATPase regulatory subunit 2 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 6 | 0 | 1 | 0 | 1 |
Proteasomal ubiquitin receptor ADRM1 | 0 | 1 | 0 | 1 |
ATP-dependent Clp protease proteolytic subunit | 0 | 1 | 1 | 2 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha-type 8 | 0 | 1 | 0 | 2 |
Proteasome subunit beta type-7 | 0 | 1 | 0 | 2 |
26S proteasome non-ATPase regulatory subunit 1 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 13 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 3 | 0 | 4 |
relaxin receptor 1 isoform 1 | 5 | 0 | 0 | 5 |
Genome polyprotein | 0 | 3 | 2 | 5 |
ATP-dependent translocase ABCB1 | 0 | 9 | 0 | 9 |
5-hydroxytryptamine receptor 1A | 0 | 6 | 0 | 6 |
D(2) dopamine receptor | 0 | 13 | 2 | 16 |
D | 0 | 6 | 0 | 6 |
D(3) dopamine receptor | 0 | 9 | 0 | 9 |
ATP-dependent translocase ABCB1 | 0 | 9 | 1 | 10 |
Alpha-2C adrenergic receptor | 0 | 13 | 3 | 16 |
Alpha-2A adrenergic receptor | 0 | 13 | 3 | 16 |
D(1B) dopamine receptor | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 2A | 0 | 18 | 2 | 20 |
5-hydroxytryptamine receptor 1B | 0 | 19 | 0 | 19 |
D(4) dopamine receptor | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 2B | 0 | 22 | 1 | 23 |
5-hydroxytryptamine receptor 6 | 0 | 15 | 1 | 16 |
Nuclear hormone receptor family member daf-12 | 0 | 0 | 1 | 1 |
oxysterols receptor LXR-beta isoform 1 | 0 | 0 | 1 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 4 |
Thymidylate kinase | 0 | 2 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 4 |
Thymidylate kinase | 0 | 4 | 0 | 4 |
Matrix metalloproteinase-9 | 0 | 3 | 0 | 3 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 3 | 4 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 15 | 1 | 16 |
Amine oxidase [flavin-containing] A | 0 | 9 | 0 | 9 |
Amine oxidase [flavin-containing] B | 0 | 8 | 0 | 8 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 9 | 1 | 11 |
Vasopressin V2 receptor | 0 | 0 | 0 | 2 |
Serine/threonine-protein kinase mTOR | 0 | 4 | 2 | 6 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 2 | 1 | 3 |
DNA-dependent protein kinase catalytic subunit | 0 | 3 | 0 | 3 |
Adenylate cyclase type 1 | 0 | 1 | 1 | 4 |
Chitotriosidase-1 | 0 | 4 | 1 | 5 |
Serine-protein kinase ATM | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase ATR | 0 | 2 | 2 | 4 |
Adenosine receptor A2b | 0 | 1 | 0 | 3 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 3 | 4 |
Endochitinase B1 | 0 | 4 | 1 | 5 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 3 | 1 | 4 |
NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 3 | 0 | 3 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 1 | 2 |
Corticotropin-releasing factor receptor 2 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 4 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 0 | 1 | 1 |
Vpr | 5 | 0 | 0 | 5 |
Albumin | 0 | 0 | 4 | 4 |
Major prion protein | 0 | 0 | 3 | 3 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 3 | 0 | 13 |
Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 4 |
Sodium channel protein type 9 subunit alpha | 0 | 5 | 0 | 5 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 2 | 0 | 2 |
Complement C5 | 0 | 0 | 1 | 1 |
Solute carrier family 15 member 1 | 0 | 6 | 0 | 7 |
Solute carrier family 22 member 11 | 0 | 8 | 0 | 13 |
Solute carrier family 22 member 8 | 0 | 9 | 0 | 10 |
Beta-lactamase | 0 | 1 | 0 | 4 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Glutathione peroxidase 1 | 0 | 1 | 0 | 1 |
Microsomal glutathione S-transferase 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 5 | 0 | 9 |
Solute carrier family 22 member 7 | 0 | 5 | 0 | 9 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 4 |
Beta-lactamase | 0 | 1 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 1 | 0 | 3 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 1 | 0 | 4 |
Albumin | 0 | 8 | 15 | 29 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 4 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 4 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-b-lactamase | 0 | 0 | 0 | 4 |
BlaVIM-1 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 4 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 4 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 4 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 3 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
thyrotropin-releasing hormone receptor | 8 | 0 | 0 | 8 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 3 |
Prostaglandin E synthase | 0 | 3 | 0 | 3 |
3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 1 | 2 |
Cytochrome c oxidase subunit 1 | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 4 | 0 | 4 |
Procathepsin L | 0 | 4 | 3 | 7 |
Aldo-keto reductase family 1 member B1 | 0 | 18 | 0 | 18 |
Neuronal acetylcholine receptor subunit alpha-4 | 3 | 2 | 0 | 5 |
Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 3 | 2 | 0 | 5 |
Beta-3 adrenergic receptor | 0 | 13 | 4 | 17 |
Alpha-1B adrenergic receptor | 0 | 28 | 3 | 31 |
Calpain-2 catalytic subunit | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Sodium-dependent noradrenaline transporter | 0 | 19 | 1 | 20 |
Cruzipain | 0 | 2 | 0 | 2 |
Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 4 | 0 | 4 |
Sodium-dependent serotonin transporter | 0 | 14 | 0 | 14 |
Bifunctional epoxide hydrolase 2 | 0 | 4 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 28 | 4 | 32 |
Sodium-dependent dopamine transporter | 0 | 18 | 0 | 18 |
Prostaglandin G/H synthase 2 | 0 | 9 | 0 | 10 |
Mitogen-activated protein kinase 14 | 0 | 3 | 6 | 9 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Cyclooxygenase-2 | 0 | 2 | 0 | 2 |
Rap guanine nucleotide exchange factor 4 | 5 | 0 | 0 | 5 |
P2Y purinoceptor 12 | 0 | 3 | 1 | 4 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 12 | 12 |
Solute carrier family 22 member 5 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 4 |
Beta-lactamase OXA-10 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase TEM | 0 | 2 | 0 | 5 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Efflux transporter | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Histamine H1 receptor | 0 | 5 | 2 | 7 |
Angiopoietin-1 receptor | 0 | 0 | 2 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 11 | 0 | 11 |
Histamine H4 receptor | 0 | 4 | 3 | 7 |
pyruvate kinase | 3 | 0 | 0 | 3 |
perilipin-5 | 0 | 2 | 0 | 2 |
perilipin-1 | 0 | 2 | 0 | 2 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 2 | 0 | 2 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 11 | 0 | 12 |
Pancreatic triacylglycerol lipase | 0 | 3 | 0 | 3 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 4 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Tubulin beta-4A chain | 0 | 5 | 3 | 10 |
Tubulin beta chain | 0 | 5 | 3 | 10 |
Tubulin alpha-3C chain | 0 | 5 | 3 | 10 |
Tumor necrosis factor receptor superfamily member 1A | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 3 | 0 | 0 | 3 |
Endothelin-1 receptor | 3 | 1 | 0 | 4 |
Quinone oxidoreductase | 0 | 0 | 0 | 1 |
Stromal cell-derived factor 1 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Tubulin alpha-1B chain | 0 | 5 | 3 | 10 |
Tubulin alpha-4A chain | 0 | 5 | 3 | 10 |
Tubulin beta-4B chain | 0 | 5 | 3 | 10 |
Tubulin beta-3 chain | 0 | 5 | 3 | 10 |
Tubulin beta-2A chain | 0 | 5 | 3 | 10 |
Tubulin beta-8 chain | 0 | 5 | 3 | 10 |
Tubulin alpha-3E chain | 0 | 5 | 3 | 10 |
Tubulin alpha-1A chain | 0 | 5 | 3 | 10 |
Sortase A | 0 | 2 | 0 | 2 |
Tubulin alpha-1C chain | 0 | 5 | 3 | 10 |
Tubulin beta-6 chain | 0 | 5 | 3 | 10 |
Tubulin beta-2B chain | 0 | 5 | 3 | 10 |
Tubulin beta-1 chain | 0 | 5 | 3 | 10 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 9 | 9 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 2 |
30S ribosomal protein S6 | 0 | 4 | 0 | 4 |
30S ribosomal protein S7 | 0 | 4 | 0 | 4 |
50S ribosomal protein L15 | 0 | 4 | 0 | 4 |
50S ribosomal protein L10 | 0 | 4 | 0 | 4 |
50S ribosomal protein L11 | 0 | 4 | 0 | 4 |
50S ribosomal protein L7/L12 | 0 | 4 | 0 | 4 |
50S ribosomal protein L19 | 0 | 4 | 0 | 4 |
50S ribosomal protein L1 | 0 | 4 | 0 | 4 |
50S ribosomal protein L20 | 0 | 4 | 0 | 4 |
50S ribosomal protein L27 | 0 | 4 | 0 | 4 |
50S ribosomal protein L28 | 0 | 4 | 0 | 4 |
50S ribosomal protein L29 | 0 | 4 | 0 | 4 |
50S ribosomal protein L31 | 0 | 4 | 0 | 4 |
50S ribosomal protein L31 type B | 0 | 4 | 0 | 4 |
50S ribosomal protein L32 | 0 | 4 | 0 | 4 |
50S ribosomal protein L33 | 0 | 4 | 0 | 4 |
50S ribosomal protein L34 | 0 | 4 | 0 | 4 |
50S ribosomal protein L35 | 0 | 4 | 0 | 4 |
50S ribosomal protein L36 | 0 | 4 | 0 | 4 |
30S ribosomal protein S10 | 0 | 4 | 0 | 4 |
30S ribosomal protein S11 | 0 | 4 | 0 | 4 |
30S ribosomal protein S12 | 0 | 4 | 0 | 4 |
30S ribosomal protein S13 | 0 | 4 | 0 | 4 |
30S ribosomal protein S16 | 0 | 4 | 0 | 4 |
30S ribosomal protein S18 | 0 | 4 | 0 | 4 |
30S ribosomal protein S19 | 0 | 4 | 0 | 4 |
30S ribosomal protein S20 | 0 | 4 | 0 | 4 |
30S ribosomal protein S2 | 0 | 4 | 0 | 4 |
30S ribosomal protein S3 | 0 | 4 | 0 | 4 |
30S ribosomal protein S4 | 0 | 4 | 0 | 4 |
30S ribosomal protein S5 | 0 | 4 | 0 | 4 |
30S ribosomal protein S8 | 0 | 4 | 0 | 4 |
30S ribosomal protein S9 | 0 | 4 | 0 | 4 |
50S ribosomal protein L13 | 0 | 4 | 0 | 4 |
50S ribosomal protein L14 | 0 | 4 | 0 | 4 |
50S ribosomal protein L16 | 0 | 4 | 0 | 4 |
50S ribosomal protein L23 | 0 | 4 | 0 | 4 |
30S ribosomal protein S15 | 0 | 4 | 0 | 4 |
50S ribosomal protein L17 | 0 | 4 | 0 | 4 |
50S ribosomal protein L21 | 0 | 4 | 0 | 4 |
50S ribosomal protein L30 | 0 | 4 | 0 | 4 |
50S ribosomal protein L6 | 0 | 4 | 0 | 4 |
30S ribosomal protein S14 | 0 | 4 | 0 | 4 |
30S ribosomal protein S17 | 0 | 4 | 0 | 4 |
30S ribosomal protein S1 | 0 | 4 | 0 | 4 |
50S ribosomal protein L18 | 0 | 4 | 0 | 4 |
50S ribosomal protein L2 | 0 | 4 | 0 | 4 |
50S ribosomal protein L3 | 0 | 4 | 0 | 4 |
50S ribosomal protein L24 | 0 | 4 | 0 | 4 |
50S ribosomal protein L4 | 0 | 4 | 0 | 4 |
50S ribosomal protein L22 | 0 | 4 | 0 | 4 |
50S ribosomal protein L5 | 0 | 4 | 0 | 4 |
30S ribosomal protein S21 | 0 | 4 | 0 | 4 |
50S ribosomal protein L25 | 0 | 4 | 0 | 4 |
50S ribosomal protein L36 2 | 0 | 4 | 0 | 4 |
Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 2 | 0 | 2 |
Spike glycoprotein | 0 | 2 | 3 | 5 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 2 | 0 | 2 |
Transmembrane protease serine 2 | 0 | 2 | 3 | 5 |
Dihydrofolate reductase | 0 | 4 | 0 | 4 |
DNA ligase | 0 | 1 | 0 | 1 |
Riboflavin-binding protein | 0 | 0 | 1 | 1 |
Histidine-rich protein PFHRP-II | 0 | 2 | 0 | 3 |
Replicase polyprotein 1a | 0 | 2 | 3 | 5 |
Replicase polyprotein 1ab | 0 | 2 | 3 | 5 |
Spike glycoprotein | 0 | 1 | 1 | 2 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 1 | 6 | 7 |
DNA ligase 1 | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 2 | 0 | 2 |
Calcium-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
DNA ligase A | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
Phosphoethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 2 | 3 | 5 |
Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
NADPH oxidase 1 | 0 | 1 | 0 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 6 | 0 | 6 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 4 | 0 | 4 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 8 | 3 | 11 |
Major prion protein | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Fyn | 0 | 5 | 6 | 11 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 3 | 1 | 4 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 14 | 0 | 14 |
D(4) dopamine receptor | 0 | 6 | 0 | 7 |
D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 4 |
Alpha-1D adrenergic receptor | 0 | 17 | 3 | 20 |
Sodium-dependent dopamine transporter | 0 | 5 | 0 | 5 |
Histamine H2 receptor | 0 | 8 | 2 | 10 |
Adenylate cyclase type 2 | 0 | 2 | 1 | 3 |
Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 2 | 5 | 7 |
Melanocortin receptor 4 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 4 | 0 | 4 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
Mu-type opioid receptor | 0 | 13 | 2 | 16 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 1 | 8 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 8 | 2 | 11 |
Kappa-type opioid receptor | 0 | 12 | 2 | 15 |
Melanocortin receptor 3 | 0 | 4 | 0 | 4 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 1 | 7 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 4 | 1 | 7 |
Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 6 | 0 | 6 |
Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 3 |
Aldehyde oxidase | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 6 | 0 | 6 |
Sodium channel protein type 5 subunit alpha | 0 | 5 | 0 | 5 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 4 | 1 | 7 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 4 | 1 | 7 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 4 | 1 | 7 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
Histamine H3 receptor | 0 | 2 | 2 | 4 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
Vitamin D3 receptor | 0 | 1 | 1 | 4 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 5 | 0 | 9 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 11 | 0 | 13 |
Multidrug and toxin extrusion protein 2 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 8 | 0 | 9 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 2 | 0 | 3 |
DNA gyrase subunit A | 0 | 4 | 0 | 8 |
DNA gyrase subunit B | 0 | 4 | 0 | 8 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 2 | 0 | 3 |
DNA gyrase subunit A | 0 | 2 | 0 | 3 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 5 | 0 | 7 |
DNA gyrase subunit A | 0 | 6 | 0 | 8 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 7 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Type IV secretion-like conjugative transfer relaxase protein TraI | 0 | 1 | 0 | 1 |
72 kDa type IV collagenase | 0 | 3 | 0 | 3 |
Stromelysin-1 | 0 | 2 | 0 | 2 |
Macrophage metalloelastase | 0 | 1 | 0 | 1 |
mitogen-activated protein kinase kinase kinase kinase 2 isoform 1 | 0 | 0 | 1 | 1 |
eyes absent homolog 2 isoform a | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase kinase kinase 3 isoform 1 | 0 | 0 | 1 | 1 |
Estrogen receptor | 0 | 0 | 3 | 3 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 3 | 3 |
Alpha-1B adrenergic receptor | 0 | 0 | 2 | 2 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 8 | 0 | 9 |
Alpha-1A adrenergic receptor | 0 | 3 | 2 | 5 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 2 | 0 | 2 |
Nischarin | 0 | 2 | 0 | 2 |
serine/threonine-protein kinase PLK1 | 10 | 0 | 0 | 10 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 5 |
Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 2 | 0 | 2 |
Thromboxane A2 receptor | 0 | 2 | 2 | 4 |
Prostaglandin E2 receptor EP1 subtype | 0 | 4 | 3 | 7 |
Prostaglandin E2 receptor EP4 subtype | 0 | 4 | 1 | 5 |
Prostaglandin F2-alpha receptor | 0 | 4 | 3 | 7 |
Prostaglandin E2 receptor EP3 subtype | 0 | 4 | 3 | 7 |
Prostaglandin E2 receptor EP2 subtype | 0 | 4 | 1 | 5 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 2 | 0 | 4 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 1 | 0 | 3 | 1 | 4 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 2 | 1 | 3 |
Transporter | 0 | 3 | 0 | 3 |
PAX8 | 0 | 0 | 0 | 2 |
nuclear receptor subfamily 0 group B member 1 | 0 | 3 | 0 | 3 |
steroidogenic factor 1 | 0 | 3 | 0 | 3 |
Tubulin alpha-1A chain | 0 | 4 | 2 | 6 |
Tubulin beta chain | 0 | 4 | 2 | 6 |
Plasma kallikrein | 0 | 0 | 0 | 3 |
Serine/threonine-protein kinase pim-1 | 0 | 1 | 6 | 7 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Tubulin polymerization-promoting protein | 0 | 0 | 1 | 1 |
Tubulin beta-2B chain | 0 | 3 | 0 | 3 |
Similar to alpha-tubulin isoform 1 | 0 | 2 | 0 | 2 |
Similar to alpha-tubulin isoform 1 | 0 | 2 | 0 | 2 |
CREB-binding protein | 1 | 1 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 8 | 0 | 0 | 8 |
relaxin receptor 2 isoform 1 | 1 | 0 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 1 | 2 |
Adenylate cyclase type 8 | 0 | 0 | 1 | 1 |
Relaxin receptor 1 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 4 | 4 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Sex hormone-binding globulin | 0 | 0 | 4 | 4 |
Corticosteroid-binding globulin | 0 | 3 | 0 | 3 |
Mineralocorticoid receptor | 0 | 2 | 2 | 4 |
C-8 sterol isomerase | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1A1 | 0 | 5 | 0 | 5 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 3 | 0 | 3 |
Chain A, Breast cancer type 1 susceptibility protein | 2 | 0 | 0 | 2 |
alkaline phosphatase, intestinal | 0 | 1 | 0 | 1 |
PINK1 | 1 | 0 | 0 | 1 |
toll-like receptor 9 | 0 | 2 | 0 | 2 |
TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 5 | 0 | 0 | 5 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 0 | 1 |
hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Phospholipase A2 | 0 | 2 | 0 | 2 |
Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Heme oxygenase 1 | 0 | 3 | 0 | 3 |
Glutathione S-transferase P | 0 | 2 | 0 | 2 |
Microtubule-associated protein tau | 0 | 1 | 0 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Heme oxygenase 2 | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 2 | 6 | 8 |
Caspase-7 | 4 | 0 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
Sodium/bile acid cotransporter | 0 | 3 | 1 | 4 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 2 | 2 |
Thioredoxin reductase 1, cytoplasmic | 0 | 2 | 0 | 2 |
Thioredoxin reductase 3 | 0 | 2 | 0 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
Cysteine protease | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Thioredoxin reductase 2, mitochondrial | 0 | 2 | 0 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
Beta lactamase (plasmid) | 0 | 3 | 0 | 3 |
LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 3 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 2 | 0 | 2 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
nuclear receptor coactivator 3 isoform a | 0 | 2 | 0 | 2 |
Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 3 | 0 | 6 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 6 | 8 |
Probable deoxycytidylate deaminase | 0 | 0 | 0 | 2 |
Cytidine deaminase | 0 | 1 | 0 | 3 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
Bone morphogenetic protein receptor type-1B | 0 | 0 | 6 | 6 |
Membrane-associated progesterone receptor component 1 | 0 | 0 | 4 | 4 |
Cell division cycle 7-related protein kinase | 0 | 0 | 3 | 3 |
Serine/threonine-protein kinase PLK4 | 0 | 0 | 6 | 6 |
ATP-dependent RNA helicase DDX3X | 0 | 0 | 6 | 6 |
Pirin | 0 | 2 | 0 | 2 |
Pyridoxal kinase | 0 | 0 | 6 | 6 |
Citron Rho-interacting kinase | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase Chk1 | 0 | 1 | 6 | 7 |
Aurora kinase A | 0 | 0 | 6 | 6 |
Cyclin-G-associated kinase | 0 | 0 | 6 | 6 |
Ephrin type-B receptor 6 | 0 | 0 | 6 | 6 |
Peroxisomal acyl-coenzyme A oxidase 3 | 0 | 0 | 6 | 6 |
Receptor-interacting serine/threonine-protein kinase 2 | 0 | 1 | 6 | 7 |
Mitotic checkpoint serine/threonine-protein kinase BUB1 | 0 | 0 | 6 | 6 |
Dynamin-like 120 kDa protein, mitochondrial | 0 | 0 | 6 | 6 |
Tyrosine-protein kinase JAK2 | 0 | 5 | 5 | 12 |
Eukaryotic translation initiation factor 5B | 0 | 0 | 3 | 3 |
Rho-associated protein kinase 2 | 0 | 2 | 6 | 8 |
Serine/threonine-protein kinase ULK1 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase/endoribonuclease IRE1 | 0 | 0 | 6 | 6 |
Ribosomal protein S6 kinase alpha-5 | 0 | 1 | 6 | 7 |
U5 small nuclear ribonucleoprotein 200 kDa helicase | 0 | 0 | 6 | 6 |
Ribosomal protein S6 kinase alpha-4 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase 16 | 0 | 0 | 6 | 6 |
Cyclin-dependent kinase-like 5 | 0 | 0 | 4 | 4 |
Serine/threonine-protein kinase 10 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase D3 | 0 | 1 | 7 | 8 |
Structural maintenance of chromosomes protein 2 | 0 | 0 | 5 | 5 |
Mitogen-activated protein kinase kinase kinase 6 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase kinase kinase kinase 4 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase LATS1 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase PAK 4 | 0 | 0 | 6 | 6 |
Tyrosine-protein kinase ABL1 | 0 | 3 | 8 | 11 |
GTPase KRas | 0 | 2 | 0 | 2 |
RAF proto-oncogene serine/threonine-protein kinase | 0 | 2 | 2 | 6 |
High affinity nerve growth factor receptor | 0 | 0 | 6 | 6 |
Guanine nucleotide-binding protein G(i) subunit alpha-2 | 0 | 0 | 4 | 4 |
ADP/ATP translocase 2 | 0 | 0 | 6 | 6 |
Protein kinase C beta type | 0 | 3 | 7 | 10 |
Insulin receptor | 0 | 3 | 6 | 9 |
Tyrosine-protein kinase Lck | 0 | 2 | 6 | 8 |
Glycogen phosphorylase, liver form | 0 | 0 | 6 | 6 |
Tyrosine-protein kinase Fes/Fps | 0 | 0 | 6 | 6 |
Adenine phosphoribosyltransferase | 0 | 0 | 5 | 5 |
Tyrosine-protein kinase Lyn | 0 | 1 | 6 | 7 |
Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 1 | 6 | 7 |
Insulin-like growth factor 1 receptor | 0 | 2 | 6 | 8 |
Signal recognition particle receptor subunit alpha | 0 | 0 | 5 | 5 |
Cytochrome c1, heme protein, mitochondrial | 0 | 0 | 6 | 6 |
Tyrosine-protein kinase HCK | 0 | 1 | 6 | 7 |
Platelet-derived growth factor receptor beta | 0 | 1 | 6 | 7 |
Tyrosine-protein kinase Fgr | 0 | 1 | 4 | 5 |
Serine/threonine-protein kinase A-Raf | 0 | 2 | 6 | 8 |
Glycogen phosphorylase, brain form | 0 | 0 | 6 | 6 |
Breakpoint cluster region protein | 0 | 1 | 7 | 8 |
Fibroblast growth factor receptor 1 | 0 | 0 | 6 | 6 |
Cyclin-dependent kinase 4 | 0 | 0 | 6 | 6 |
ADP/ATP translocase 3 | 0 | 0 | 6 | 6 |
Inosine-5'-monophosphate dehydrogenase 2 | 0 | 2 | 5 | 7 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 6 | 7 |
cAMP-dependent protein kinase type II-alpha regulatory subunit | 0 | 0 | 5 | 5 |
Serine/threonine-protein kinase B-raf | 0 | 2 | 8 | 12 |
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 0 | 0 | 6 | 6 |
Tyrosine-protein kinase Fer | 0 | 0 | 6 | 6 |
Protein kinase C alpha type | 0 | 3 | 7 | 10 |
cAMP-dependent protein kinase catalytic subunit alpha | 0 | 0 | 6 | 6 |
General transcription and DNA repair factor IIH helicase subunit XPD | 0 | 0 | 6 | 6 |
Ras-related protein Rab-6A | 0 | 0 | 6 | 6 |
Ephrin type-A receptor 1 | 0 | 0 | 6 | 6 |
Multifunctional protein ADE2 | 0 | 0 | 6 | 6 |
cAMP-dependent protein kinase catalytic subunit gamma | 0 | 0 | 4 | 4 |
cAMP-dependent protein kinase catalytic subunit beta | 0 | 0 | 6 | 6 |
Ferrochelatase, mitochondrial | 0 | 0 | 7 | 7 |
Ribosomal protein S6 kinase beta-1 | 0 | 1 | 6 | 7 |
Tyrosine-protein kinase JAK1 | 0 | 5 | 7 | 14 |
Cyclin-dependent kinase 2 | 0 | 4 | 7 | 11 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 7 | 7 |
Probable ATP-dependent RNA helicase DDX6 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase 3 | 0 | 0 | 6 | 6 |
MAP/microtubule affinity-regulating kinase 3 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase 1 | 0 | 3 | 6 | 9 |
Ephrin type-A receptor 2 | 0 | 1 | 6 | 7 |
Ephrin type-B receptor 2 | 0 | 0 | 6 | 6 |
Non-receptor tyrosine-protein kinase TYK2 | 0 | 3 | 7 | 12 |
UMP-CMP kinase | 0 | 0 | 4 | 4 |
Phosphatidylethanolamine-binding protein 1 | 0 | 0 | 5 | 5 |
Wee1-like protein kinase | 0 | 0 | 6 | 6 |
Heme oxygenase 2 | 0 | 0 | 6 | 6 |
S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 6 | 6 |
DnaJ homolog subfamily A member 1 | 0 | 0 | 6 | 6 |
RAC-alpha serine/threonine-protein kinase | 0 | 1 | 6 | 7 |
RAC-beta serine/threonine-protein kinase | 0 | 0 | 6 | 6 |
Dual specificity protein kinase TTK | 0 | 0 | 4 | 4 |
DNA replication licensing factor MCM4 | 0 | 0 | 5 | 5 |
Myosin-10 | 0 | 0 | 5 | 5 |
Dual specificity mitogen-activated protein kinase kinase 2 | 0 | 3 | 6 | 9 |
Bone morphogenetic protein receptor type-1A | 0 | 0 | 6 | 6 |
Activin receptor type-1B | 0 | 0 | 6 | 6 |
TGF-beta receptor type-1 | 0 | 1 | 6 | 7 |
Serine/threonine-protein kinase receptor R3 | 0 | 0 | 3 | 3 |
TGF-beta receptor type-2 | 0 | 0 | 5 | 5 |
Electron transfer flavoprotein subunit beta | 0 | 0 | 4 | 4 |
Tyrosine-protein kinase CSK | 0 | 2 | 6 | 8 |
Glycine--tRNA ligase | 0 | 0 | 6 | 6 |
Protein kinase C iota type | 0 | 1 | 7 | 8 |
Exosome RNA helicase MTR4 | 0 | 0 | 6 | 6 |
Tyrosine-protein kinase Tec | 0 | 2 | 6 | 8 |
Tyrosine-protein kinase ABL2 | 0 | 0 | 6 | 6 |
Tyrosine-protein kinase FRK | 0 | 1 | 6 | 7 |
Tyrosine-protein kinase SYK | 0 | 1 | 6 | 7 |
Mitogen-activated protein kinase 8 | 0 | 1 | 6 | 7 |
Mitogen-activated protein kinase 9 | 0 | 0 | 6 | 6 |
Dual specificity mitogen-activated protein kinase kinase 4 | 0 | 0 | 3 | 3 |
Dual specificity mitogen-activated protein kinase kinase 3 | 0 | 0 | 6 | 6 |
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0 | 0 | 5 | 5 |
Casein kinase I isoform alpha | 0 | 0 | 5 | 5 |
Casein kinase I isoform delta | 0 | 0 | 6 | 6 |
MAP kinase-activated protein kinase 2 | 0 | 1 | 6 | 7 |
Elongation factor Tu, mitochondrial | 0 | 0 | 6 | 6 |
Choline-phosphate cytidylyltransferase A | 0 | 0 | 3 | 3 |
Cysteine--tRNA ligase, cytoplasmic | 0 | 0 | 5 | 5 |
Casein kinase I isoform epsilon | 0 | 0 | 6 | 6 |
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | 0 | 0 | 6 | 6 |
Dual specificity protein kinase CLK1 | 0 | 0 | 6 | 6 |
Dual specificity protein kinase CLK2 | 0 | 0 | 6 | 6 |
Dual specificity protein kinase CLK3 | 0 | 0 | 4 | 4 |
Glycogen synthase kinase-3 alpha | 0 | 0 | 6 | 6 |
Cyclin-dependent kinase 7 | 0 | 1 | 6 | 7 |
Cyclin-dependent kinase 9 | 0 | 1 | 6 | 7 |
Ras-related protein Rab-27A | 0 | 0 | 5 | 5 |
Interleukin-1 receptor-associated kinase 1 | 0 | 0 | 6 | 6 |
Ribosomal protein S6 kinase alpha-3 | 0 | 1 | 6 | 7 |
Serine/threonine-protein kinase Nek2 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase Nek3 | 0 | 0 | 6 | 6 |
Dual specificity mitogen-activated protein kinase kinase 6 | 0 | 0 | 6 | 6 |
LIM domain kinase 1 | 0 | 0 | 6 | 6 |
LIM domain kinase 2 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase 10 | 0 | 0 | 6 | 6 |
Tyrosine--tRNA ligase, cytoplasmic | 0 | 0 | 6 | 6 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 6 | 6 |
Ephrin type-B receptor 3 | 0 | 0 | 6 | 6 |
Ephrin type-A receptor 5 | 0 | 0 | 6 | 6 |
Ephrin type-B receptor 4 | 0 | 0 | 6 | 6 |
Ephrin type-A receptor 4 | 0 | 0 | 6 | 6 |
Adenylate kinase 2, mitochondrial | 0 | 0 | 6 | 7 |
Adenosine kinase | 0 | 0 | 6 | 6 |
Ras-related protein Rab-10 | 0 | 0 | 6 | 6 |
Actin-related protein 3 | 0 | 0 | 6 | 6 |
Actin-related protein 2 | 0 | 0 | 5 | 5 |
GTP-binding nuclear protein Ran | 0 | 0 | 6 | 6 |
Casein kinase I isoform gamma-2 | 0 | 0 | 6 | 6 |
Cyclin-dependent kinase 3 | 0 | 0 | 5 | 5 |
Cyclin-dependent kinase 6 | 0 | 0 | 6 | 6 |
Cyclin-dependent-like kinase 5 | 0 | 1 | 6 | 7 |
Cyclin-dependent kinase 16 | 0 | 0 | 6 | 6 |
Cyclin-dependent kinase 17 | 0 | 0 | 6 | 6 |
Heat shock factor protein 1 | 0 | 2 | 0 | 2 |
ATP-dependent 6-phosphofructokinase, platelet type | 0 | 0 | 6 | 6 |
Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 2 | 6 | 8 |
DNA topoisomerase 2-beta | 0 | 0 | 6 | 6 |
Protein kinase C theta type | 0 | 1 | 7 | 8 |
Activin receptor type-1 | 0 | 0 | 6 | 6 |
Macrophage-stimulating protein receptor | 0 | 0 | 6 | 6 |
Focal adhesion kinase 1 | 0 | 0 | 6 | 6 |
Protein kinase C zeta type | 0 | 1 | 3 | 4 |
Protein kinase C delta type | 0 | 2 | 7 | 9 |
Tyrosine-protein kinase BTK | 0 | 3 | 7 | 10 |
Activated CDC42 kinase 1 | 0 | 0 | 6 | 6 |
Epithelial discoidin domain-containing receptor 1 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase kinase kinase kinase 2 | 0 | 0 | 6 | 6 |
Tyrosine-protein kinase Mer | 0 | 0 | 5 | 5 |
Serine/threonine-protein kinase 4 | 0 | 0 | 6 | 6 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 6 | 6 |
Dual specificity mitogen-activated protein kinase kinase 5 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase 7 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase PAK 2 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase 3 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase kinase kinase 1 | 0 | 0 | 6 | 6 |
Integrin-linked protein kinase | 0 | 0 | 6 | 6 |
Rho-associated protein kinase 1 | 0 | 1 | 6 | 7 |
Non-receptor tyrosine-protein kinase TNK1 | 0 | 0 | 6 | 6 |
Receptor-interacting serine/threonine-protein kinase 1 | 0 | 1 | 1 | 2 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma | 0 | 0 | 6 | 6 |
Calcium/calmodulin-dependent protein kinase type II subunit delta | 0 | 0 | 6 | 6 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 6 | 6 |
Activin receptor type-2B | 0 | 0 | 6 | 6 |
Bone morphogenetic protein receptor type-2 | 0 | 0 | 6 | 6 |
Protein-tyrosine kinase 6 | 0 | 1 | 6 | 7 |
cGMP-dependent protein kinase 1 | 0 | 0 | 6 | 6 |
Cyclin-dependent kinase 13 | 0 | 0 | 6 | 6 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 0 | 0 | 6 | 6 |
Protein-tyrosine kinase 2-beta | 0 | 0 | 6 | 6 |
Maternal embryonic leucine zipper kinase | 0 | 0 | 6 | 6 |
Structural maintenance of chromosomes protein 1A | 0 | 0 | 5 | 5 |
Chromodomain-helicase-DNA-binding protein 4 | 0 | 0 | 6 | 6 |
Peroxisomal acyl-coenzyme A oxidase 1 | 0 | 0 | 4 | 4 |
Cyclin-dependent kinase 10 | 0 | 0 | 2 | 2 |
Ephrin type-A receptor 7 | 0 | 0 | 4 | 4 |
Delta(24)-sterol reductase | 0 | 0 | 5 | 5 |
Ribosomal protein S6 kinase alpha-1 | 0 | 1 | 6 | 7 |
Dual specificity testis-specific protein kinase 1 | 0 | 0 | 3 | 3 |
Myosin light chain kinase, smooth muscle | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase 11 | 0 | 1 | 6 | 7 |
Serine/threonine-protein kinase STK11 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase N1 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase N2 | 0 | 0 | 6 | 6 |
Calcium/calmodulin-dependent protein kinase type IV | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase kinase kinase 11 | 0 | 0 | 6 | 6 |
MAP kinase-activated protein kinase 3 | 0 | 0 | 3 | 3 |
Discoidin domain-containing receptor 2 | 0 | 0 | 6 | 6 |
AP2-associated protein kinase 1 | 0 | 0 | 6 | 6 |
Myosin light chain kinase 3 | 0 | 0 | 6 | 6 |
Uncharacterized aarF domain-containing protein kinase 5 | 0 | 0 | 4 | 4 |
Putative heat shock protein HSP 90-beta 2 | 0 | 0 | 6 | 6 |
Rab-like protein 3 | 0 | 0 | 4 | 4 |
Serine/threonine-protein kinase MRCK alpha | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase MRCK gamma | 0 | 0 | 6 | 6 |
Acyl-CoA dehydrogenase family member 10 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase N3 | 0 | 0 | 4 | 4 |
Serine/threonine-protein kinase ULK3 | 0 | 0 | 6 | 6 |
Dual serine/threonine and tyrosine protein kinase | 0 | 1 | 1 | 2 |
Uncharacterized protein FLJ45252 | 0 | 0 | 6 | 6 |
Acyl-CoA dehydrogenase family member 11 | 0 | 0 | 4 | 4 |
Serine/threonine-protein kinase/endoribonuclease IRE2 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase MARK2 | 0 | 0 | 6 | 6 |
ATP-dependent RNA helicase DHX30 | 0 | 0 | 5 | 5 |
Serine/threonine-protein kinase TAO1 | 0 | 0 | 6 | 6 |
STE20-related kinase adapter protein alpha | 0 | 0 | 6 | 6 |
Myosin-14 | 0 | 0 | 6 | 6 |
AarF domain-containing protein kinase 1 | 0 | 0 | 6 | 6 |
ATP-dependent RNA helicase DDX42 | 0 | 0 | 4 | 4 |
Mitogen-activated protein kinase kinase kinase kinase 3 | 0 | 0 | 6 | 6 |
MAP kinase-activated protein kinase 5 | 0 | 1 | 6 | 7 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B | 0 | 0 | 3 | 3 |
Misshapen-like kinase 1 | 0 | 0 | 5 | 5 |
Atypical kinase COQ8A, mitochondrial | 0 | 0 | 6 | 6 |
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase 15 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase Nek9 | 0 | 0 | 6 | 6 |
ATP-dependent RNA helicase DDX1 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase kinase kinase kinase 1 | 0 | 0 | 6 | 6 |
MAP/microtubule affinity-regulating kinase 4 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase Nek1 | 0 | 0 | 6 | 6 |
PAS domain-containing serine/threonine-protein kinase | 0 | 0 | 4 | 4 |
Calcium/calmodulin-dependent protein kinase kinase 2 | 0 | 0 | 6 | 6 |
EKC/KEOPS complex subunit TP53RK | 0 | 0 | 6 | 6 |
Dual specificity testis-specific protein kinase 2 | 0 | 0 | 5 | 5 |
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase kinase kinase 5 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase kinase kinase 3 | 0 | 0 | 6 | 6 |
Eukaryotic translation initiation factor 2-alpha kinase 1 | 0 | 0 | 6 | 6 |
Nucleolar GTP-binding protein 1 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase D2 | 0 | 0 | 6 | 6 |
NUAK family SNF1-like kinase 2 | 0 | 0 | 5 | 5 |
RNA cytidine acetyltransferase | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase SIK2 | 0 | 0 | 6 | 6 |
STE20-like serine/threonine-protein kinase | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase TAO3 | 0 | 0 | 6 | 6 |
dCTP pyrophosphatase 1 | 0 | 0 | 6 | 6 |
Dual specificity protein kinase CLK4 | 0 | 0 | 6 | 6 |
Casein kinase I isoform gamma-1 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase PAK 6 | 0 | 0 | 3 | 3 |
Phenylalanine--tRNA ligase beta subunit | 0 | 0 | 6 | 6 |
Isoleucine--tRNA ligase, mitochondrial | 0 | 0 | 3 | 3 |
BMP-2-inducible protein kinase | 0 | 0 | 6 | 6 |
Obg-like ATPase 1 | 0 | 0 | 5 | 5 |
Midasin | 0 | 0 | 6 | 6 |
Interleukin-1 receptor-associated kinase 4 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase kinase kinase 20 | 0 | 1 | 6 | 7 |
Cyclin-dependent kinase 12 | 0 | 0 | 6 | 6 |
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | 0 | 0 | 5 | 5 |
Serine/threonine-protein kinase pim-2 | 0 | 0 | 3 | 3 |
Serine/threonine-protein kinase 26 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase NLK | 0 | 0 | 6 | 6 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase TBK1 | 0 | 1 | 6 | 7 |
Septin-9 | 0 | 0 | 6 | 6 |
Ribosomal protein S6 kinase alpha-6 | 0 | 0 | 6 | 6 |
TRAF2 and NCK-interacting protein kinase | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase TAO2 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase ICK | 0 | 0 | 6 | 6 |
RAC-gamma serine/threonine-protein kinase | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase SIK3 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase kinase kinase 2 | 0 | 0 | 6 | 6 |
Thyroid hormone receptor-associated protein 3 | 0 | 0 | 6 | 6 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0 | 0 | 5 | 5 |
Mitogen-activated protein kinase kinase kinase kinase 5 | 0 | 0 | 6 | 6 |
Receptor-interacting serine/threonine-protein kinase 3 | 0 | 1 | 6 | 7 |
Serine/threonine-protein kinase MRCK beta | 0 | 0 | 6 | 6 |
Interleukin-1 receptor-associated kinase 3 | 0 | 0 | 6 | 6 |
Serine/threonine-protein kinase 24 | 0 | 0 | 4 | 4 |
Casein kinase I isoform gamma-3 | 0 | 0 | 6 | 6 |
Mitogen-activated protein kinase kinase kinase 4 | 0 | 0 | 6 | 6 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 11 | 0 | 0 | 11 |
Estrogen receptor | 0 | 8 | 0 | 8 |
6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 8 | 0 | 9 |
Lysine-specific demethylase 4A | 0 | 1 | 0 | 1 |
Hypoxia-inducible factor 1-alpha | 0 | 0 | 1 | 1 |
Methylcytosine dioxygenase TET2 | 0 | 1 | 0 | 1 |
Deoxyhypusine hydroxylase | 0 | 1 | 0 | 1 |
Thymidine kinase 2 | 0 | 1 | 0 | 1 |
AAA family ATPase | 0 | 0 | 0 | 1 |
phosphoglycerate kinase | 2 | 0 | 0 | 2 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 2 | 0 | 0 | 2 |
Aldo-keto reductase family 1 member B10 | 0 | 4 | 0 | 4 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 3 | 3 |
Transthyretin | 0 | 3 | 5 | 13 |
Interleukin-8 | 0 | 3 | 0 | 3 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 6 | 1 | 7 |
Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A7 | 0 | 2 | 0 | 3 |
UDP-glucuronosyltransferase 1A10 | 0 | 2 | 0 | 3 |
electroneutral potassium-chloride cotransporter KCC2 | 0 | 0 | 1 | 1 |
High mobility group protein B1 | 0 | 0 | 2 | 2 |
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase | 0 | 2 | 0 | 2 |
Cereblon isoform 4 | 0 | 4 | 0 | 4 |
Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Protein cereblon | 0 | 6 | 1 | 8 |
Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, Pol Polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol Polyprotein | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 5 | 0 | 5 |
Gag-Pol polyprotein | 0 | 6 | 0 | 6 |
Acetylcholinesterase | 0 | 0 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
Microsomal triglyceride transfer protein large subunit | 0 | 1 | 0 | 1 |
Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120 | 0 | 1 | 0 | 1 |
Protease | 0 | 8 | 5 | 23 |
Fructose-1,6-bisphosphatase 1 | 0 | 0 | 0 | 1 |
Reverse transcriptase | 0 | 1 | 1 | 2 |
Cholesterol 24-hydroxylase | 0 | 0 | 1 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
ubiquitin-conjugating enzyme E2 N | 0 | 2 | 0 | 2 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
Endothelin-1 receptor | 0 | 2 | 1 | 3 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase B-raf | 0 | 2 | 0 | 2 |
Flavin reductase (NADPH) | 0 | 0 | 2 | 2 |
large T antigen | 0 | 4 | 0 | 4 |
Pantothenate synthetase | 0 | 2 | 0 | 2 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
unnamed protein product | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 5 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 2 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
Malate dehydrogenase, cytoplasmic | 0 | 2 | 0 | 2 |
Cytochrome P450 144 | 0 | 0 | 3 | 3 |
Steroid C26-monooxygenase | 0 | 0 | 3 | 3 |
Steroid C26-monooxygenase | 0 | 0 | 3 | 3 |
Mycocyclosin synthase | 0 | 0 | 2 | 2 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 2 | 2 |
Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Sterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 4 |
likely tRNA 2'-phosphotransferase | 0 | 1 | 0 | 1 |
corticotropin-releasing hormone receptor 2 | 0 | 2 | 2 | 4 |
corticotropin releasing factor-binding protein | 0 | 2 | 2 | 4 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 2 | 2 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 2 |
Chain A, PROTEIN (TRANSTHYRETIN) | 0 | 0 | 1 | 1 |
Chain B, PROTEIN (TRANSTHYRETIN) | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C4 | 0 | 4 | 0 | 4 |
Transcription factor SOX-18 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C1 | 0 | 4 | 0 | 4 |
Peroxisome proliferator-activated receptor alpha | 2 | 0 | 0 | 2 |
Transcriptional enhancer factor TEF-3 | 0 | 1 | 1 | 2 |
Potassium channel subfamily K member 18 | 0 | 0 | 1 | 1 |
Acid-sensing ion channel 5 | 0 | 0 | 1 | 1 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 5 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
Acid-sensing ion channel 3 | 0 | 2 | 0 | 2 |
Acid-sensing ion channel 1 | 0 | 2 | 0 | 2 |
Chain A, probable fosfomycin resistance protein | 0 | 0 | 1 | 1 |
Chain B, probable fosfomycin resistance protein | 0 | 0 | 1 | 1 |
DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
DNA polymerase alpha catalytic subunit | 0 | 1 | 0 | 1 |
DNA polymerase delta catalytic subunit | 0 | 1 | 0 | 1 |
Menin | 0 | 0 | 1 | 1 |
Lecithin retinol acyltransferase | 0 | 1 | 0 | 1 |
Lethal factor | 0 | 1 | 0 | 1 |
Protein Rev | 0 | 0 | 2 | 2 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 5 | 0 | 0 | 5 |
Chain A, Type Iii Chloramphenicol Acetyltransferase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
ClpP | 4 | 0 | 0 | 4 |
Transitional endoplasmic reticulum ATPase | 0 | 1 | 0 | 1 |
Asialoglycoprotein receptor 1 | 0 | 1 | 1 | 2 |
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 2 |
Ricin | 0 | 1 | 0 | 1 |
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | 0 | 0 | 1 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
Macrophage migration inhibitory factor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 2 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 2 | 1 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Cyclic GMP-AMP synthase | 0 | 1 | 0 | 1 |
Toll-like receptor 9 | 0 | 1 | 0 | 1 |
Toll-like receptor 7 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Amino acid transporter | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A4 | 0 | 4 | 0 | 5 |
Caspase-1 | 0 | 6 | 0 | 7 |
Caspase-3 | 0 | 4 | 0 | 4 |
Caspase-4 | 0 | 4 | 0 | 4 |
Caspase-5 | 0 | 4 | 0 | 4 |
Caspase-9 | 0 | 4 | 0 | 4 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
Mast/stem cell growth factor receptor Kit | 0 | 1 | 2 | 3 |
Platelet-derived growth factor receptor alpha | 0 | 1 | 2 | 3 |
Cytochrome P450 3A5 | 0 | 2 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Chain A, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain B, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain A, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain B, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain A, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain A, HIV-II PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-II PROTEASE | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 2 | 0 | 2 |
Chain B, POL polyprotein | 0 | 2 | 0 | 2 |
Chain A, POL polyprotein | 0 | 2 | 0 | 2 |
Chain B, POL polyprotein | 0 | 2 | 0 | 2 |
Chain A, HIV-1 protease | 0 | 1 | 0 | 1 |
Chain B, HIV-1 protease | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 5 | 0 | 5 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Gag polyprotein | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 3 | 0 | 3 |
Gag-Pol polyprotein | 0 | 3 | 0 | 3 |
Thromboxane-A synthase | 0 | 0 | 0 | 3 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Protease | 0 | 7 | 3 | 10 |
Protease | 0 | 1 | 0 | 1 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 8 | 0 | 9 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 2 | 0 | 3 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 4 | 4 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 2 | 0 | 5 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
Isocitrate lyase | 0 | 1 | 0 | 1 |
Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 8 | 5 | 14 |
Beta-2 adrenergic receptor | 0 | 4 | 1 | 6 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 3 | 1 | 4 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 2 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 2 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 4 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 4 |
Retinoic acid receptor beta | 0 | 2 | 2 | 4 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 2 | 2 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
Cellular retinoic acid-binding protein 1 | 0 | 2 | 0 | 3 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 2 | 2 |
Olfactory receptor 51E2 | 0 | 1 | 0 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
Gap junction alpha-1 protein | 0 | 1 | 0 | 1 |
Gap junction beta-2 protein | 0 | 1 | 0 | 1 |
Acyl-protein thioesterase 1 | 0 | 1 | 0 | 1 |
Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
matrix metalloproteinase 1, partial | 0 | 0 | 1 | 1 |
Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 4 | 0 | 4 |
Alkaline phosphatase, placental type | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 2 | 0 | 2 |
CAAX prenyl protease 2 isoform 2 | 0 | 0 | 0 | 1 |
DNA primase | 0 | 2 | 0 | 2 |
retinoic acid receptor alpha isoform 1 | 0 | 1 | 0 | 1 |
retinoic acid receptor RXR-alpha isoform a | 0 | 1 | 0 | 1 |
DNA polymerase III, partial | 2 | 0 | 0 | 2 |
Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
microphthalmia-associated transcription factor isoform 9 | 0 | 3 | 0 | 3 |
Tumor necrosis factor | 0 | 3 | 1 | 4 |
Neuraminidase | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 2 | 0 | 2 |
Cystine/glutamate transporter | 0 | 2 | 0 | 2 |
Hydroxyacid oxidase 1 | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 7 | 3 | 11 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 3 | 0 | 4 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 4 | 0 | 5 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 3 | 0 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 3 | 0 | 3 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 4 | 0 | 4 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 5 | 0 | 5 |
Folate receptor beta | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 1 | 0 | 1 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Reduced folate transporter | 0 | 2 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
Pteridine reductase 1 | 0 | 2 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 3 | 0 | 4 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Dihydrofolate reductase | 0 | 3 | 0 | 4 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
Metabotropic glutamate receptor 6 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Epoxide hydrolase 1 | 0 | 0 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 2 |
Aromatase | 0 | 0 | 1 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
Indoleamine 2,3-dioxygenase 2 | 0 | 2 | 0 | 2 |
Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
methionyl-tRNA synthetase, putative | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | 0 | 1 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase 1 | 0 | 2 | 0 | 2 |
Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 2 |
Formyl peptide receptor-related sequence 1 | 0 | 0 | 1 | 1 |
fMet-Leu-Phe receptor | 0 | 2 | 2 | 4 |
N-formyl peptide receptor 2 | 0 | 0 | 2 | 2 |
FML2_HUMAN | 0 | 0 | 1 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 2 | 0 | 2 |
Nitric oxide synthase, endothelial | 0 | 5 | 0 | 5 |
Nitric oxide synthase, inducible | 0 | 3 | 0 | 3 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Hormone-sensitive lipase | 0 | 1 | 0 | 1 |
Chain A, Hth-type Transcriptional Regulator Ttgr | 0 | 0 | 2 | 2 |
Chain A, Hth-type Transcriptional Regulator Ttgr | 0 | 0 | 2 | 2 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 3 | 0 | 3 |
17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 2 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 3 | 0 | 3 |
Prenyltransferase homolog | 0 | 0 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
bcl-2-related protein A1 | 0 | 2 | 0 | 2 |
G protein-activated inward rectifier potassium channel 2 | 0 | 0 | 1 | 1 |
G protein-activated inward rectifier potassium channel 4 | 0 | 0 | 1 | 1 |
G protein-activated inward rectifier potassium channel 1 | 0 | 0 | 1 | 1 |
Heparanase | 0 | 0 | 1 | 1 |
Collagenase 3 | 0 | 3 | 0 | 3 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
STE24 | 0 | 0 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
Phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
Hemagglutinin [Cleaved into: Hemagglutinin HA1 chain; Hemagglutinin HA2 chain] | 0 | 0 | 1 | 1 |
DNA polymerase beta | 0 | 2 | 0 | 2 |
DNA polymerase beta | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein phosphatase C | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein phosphatase F | 0 | 1 | 0 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
Tyrosine-protein phosphatase non-receptor type 2 | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein phosphatase alpha | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein phosphatase epsilon | 0 | 1 | 0 | 1 |
Low molecular weight phosphotyrosine protein phosphatase | 0 | 2 | 0 | 2 |
Tyrosine-protein phosphatase non-receptor type 6 | 0 | 1 | 0 | 1 |
M-phase inducer phosphatase 2 | 0 | 1 | 0 | 1 |
Signal transducer and activator of transcription 3 | 0 | 1 | 0 | 1 |
Dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 11 | 0 | 1 | 0 | 1 |
Env polyprotein | 0 | 0 | 1 | 1 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 3 | 0 | 3 |
Transmembrane prolyl 4-hydroxylase | 0 | 0 | 1 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, L-ARGININE\\:GLYCINE AMIDINOTRANSFERASE | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 2 | 0 | 2 |
Sialidase | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
Sialidase-4 | 0 | 1 | 0 | 1 |
Sialidase-1 | 0 | 1 | 0 | 1 |
Sialidase-3 | 0 | 1 | 0 | 1 |
Putative nucleoside diphosphate kinase | 0 | 0 | 2 | 2 |
Receptor tyrosine-protein kinase erbB-3 | 0 | 2 | 1 | 3 |
Nucleoside diphosphate kinase B | 0 | 0 | 2 | 2 |
von Hippel-Lindau disease tumor suppressor | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 1 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase 38 | 0 | 0 | 3 | 3 |
Receptor tyrosine-protein kinase erbB-4 | 0 | 3 | 2 | 5 |
Serine/threonine-protein kinase Nek7 | 0 | 0 | 4 | 4 |
Calcium/calmodulin-dependent protein kinase type 1G | 0 | 0 | 4 | 4 |
Echinoderm microtubule-associated protein-like 4 | 0 | 0 | 1 | 1 |
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | 0 | 0 | 5 | 5 |
ALK tyrosine kinase receptor | 0 | 1 | 2 | 3 |
polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
Microphthalmia-associated transcription factor | 0 | 0 | 0 | 1 |
caspase recruitment domain family, member 15 | 0 | 2 | 0 | 2 |
receptor-interacting serine/threonine-protein kinase 2 isoform 1 | 0 | 2 | 0 | 2 |
Valosin-containing protein | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
tyrosine-protein kinase Yes | 4 | 0 | 0 | 4 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
Macrophage colony-stimulating factor 1 receptor | 0 | 1 | 1 | 2 |
G1/S-specific cyclin-E1 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase TXK | 0 | 2 | 2 | 4 |
Tyrosine-protein kinase Blk | 0 | 2 | 2 | 4 |
Cytoplasmic tyrosine-protein kinase BMX | 0 | 3 | 2 | 5 |
cAMP-dependent protein kinase catalytic subunit PRKX | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase JAK3 | 0 | 4 | 3 | 10 |
Tyrosine-protein kinase ITK/TSK | 0 | 2 | 2 | 4 |
Nuclear receptor subfamily 4 group A member 3 | 0 | 1 | 0 | 1 |
Peroxiredoxin-like 2A | 0 | 1 | 0 | 1 |
Platelet glycoprotein VI | 0 | 1 | 0 | 1 |
Succinyl-diaminopimelate desuccinylase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase 1 | 0 | 0 | 0 | 1 |
Class D beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
vasopressin V1b receptor | 1 | 0 | 0 | 1 |
Estrogen receptor 1 | 0 | 1 | 0 | 1 |
fMet-Leu-Phe receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 2 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 2 | 2 |
serine-protein kinase ATM isoform a | 2 | 0 | 0 | 2 |
fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 2 |
serine/threonine-protein kinase 33 isoform a | 0 | 0 | 1 | 1 |
Sodium/glucose cotransporter 1 | 0 | 2 | 0 | 2 |
Sodium/glucose cotransporter 2 | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger 9B2 | 0 | 1 | 0 | 1 |
Solute carrier family 28 member 3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
Complement C1s subcomponent | 0 | 1 | 0 | 1 |
Chain A, AKAP9-BRAF fusion protein | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 1 | 2 |
Dual specificity mitogen-activated protein kinase kinase 4 | 0 | 0 | 1 | 1 |
Aspartyl/asparaginyl beta-hydroxylase | 0 | 1 | 0 | 1 |
Long-chain-fatty-acid--CoA ligase 5 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase 38-like | 0 | 0 | 2 | 2 |
Regulatory protein E2 | 0 | 0 | 1 | 1 |
Regulatory protein E2 | 0 | 0 | 1 | 1 |
Regulatory protein E2 | 0 | 0 | 1 | 1 |
Calcium-activated potassium channel subunit alpha-1 | 0 | 1 | 0 | 1 |
karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b | 0 | 0 | 1 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Pannexin-1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 12 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
Pannexin-1 | 0 | 1 | 0 | 1 |
Glutamate 5-kinase | 0 | 0 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 1 | 4 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 5 | 1 | 6 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
low molecular weight phosphotyrosine protein phosphatase isoform c | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 22 isoform 1 | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Beta-hexosaminidase subunit alpha | 0 | 1 | 0 | 2 |
Beta-hexosaminidase subunit beta | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
Trace amine-associated receptor 5 | 0 | 0 | 2 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Multidrug resistance protein 1a | 0 | 0 | 0 | 1 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
NH(3)-dependent NAD(+) synthetase | 0 | 2 | 0 | 2 |
Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 2 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Chain A, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain A, Endothiapepsin | 0 | 1 | 0 | 1 |
Chain A, Endothiapepsin | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Plasmepsin V | 0 | 1 | 0 | 1 |
Retina-specific copper amine oxidase | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 5 | 0 | 5 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Protease | 0 | 0 | 1 | 1 |
Chain B, Protease | 0 | 0 | 1 | 1 |
Chain A, Protease | 0 | 0 | 1 | 1 |
Chain B, Protease | 0 | 0 | 1 | 1 |
Exoribonuclease H | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Eukaryotic translation initiation factor 4E | 0 | 0 | 1 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 4 | 3 | 7 |
Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase 18 | 0 | 0 | 2 | 2 |
Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 2 | 0 | 2 |
Programmed cell death protein 4 | 0 | 0 | 1 | 1 |
Regulatory-associated protein of mTOR | 0 | 1 | 0 | 1 |
Target of rapamycin complex subunit LST8 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Chain A, Ribosomal protein S6 kinase alpha-1 | 0 | 1 | 0 | 1 |
Chain X, Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
Chain A, Dual specificity protein kinase TTK | 0 | 0 | 1 | 1 |
Chain A, Dual specificity protein kinase TTK | 0 | 0 | 1 | 1 |
exodeoxyribonuclease V subunit RecD | 0 | 3 | 0 | 3 |
exodeoxyribonuclease V subunit RecB | 0 | 3 | 0 | 3 |
exodeoxyribonuclease V subunit RecC | 0 | 3 | 0 | 3 |
ATP-dependent 6-phosphofructokinase | 0 | 2 | 0 | 2 |
Dihydropteroate synthase | 0 | 1 | 0 | 1 |
Chain A, Glutathione S-transferase | 0 | 1 | 0 | 1 |
Interstitial collagenase | 0 | 1 | 0 | 1 |
Fibroblast growth factor 1 | 0 | 0 | 1 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 2 | 0 | 1 | 0 | 1 |
Protein kinase C gamma type | 0 | 2 | 1 | 3 |
Protein kinase C eta type | 0 | 1 | 2 | 3 |
P2Y purinoceptor 2 | 0 | 1 | 1 | 2 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 2 | 0 | 1 | 1 | 2 |
P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 4 | 0 | 0 | 1 | 1 |
NAD-dependent protein deacetylase HST2 | 0 | 1 | 0 | 1 |
P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 1 | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 3 | 2 | 5 |
P2Y purinoceptor 6 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase D1 | 0 | 1 | 2 | 3 |
Dual specificity protein phosphatase 5 | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 8 | 0 | 1 | 0 | 1 |
RmtA | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 3 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 11 | 0 | 1 | 1 | 2 |
P2X purinoceptor 7 | 0 | 0 | 1 | 1 |
Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
Corticotropin releasing hormone receptor 2 | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 6B | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 4B | 0 | 1 | 0 | 1 |
ATP-dependent molecular chaperone HSP82 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 3 | 2 | 5 |
Cholesteryl ester transfer protein | 0 | 0 | 1 | 1 |
ATP-dependent molecular chaperone HSC82 | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 5A | 0 | 1 | 0 | 1 |
Endoplasmin | 0 | 1 | 1 | 2 |
Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
Heat-shock protein | 0 | 1 | 0 | 1 |
Putative heat shock protein HSP 90-alpha A4 | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 4C | 0 | 1 | 0 | 1 |
Adenylate kinase isoenzyme 1 | 0 | 0 | 0 | 1 |
Capsid protein | 0 | 0 | 1 | 1 |
Squalene monooxygenase | 0 | 1 | 0 | 1 |
Squalene monooxygenase | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
cGMP-gated cation channel alpha-1 | 0 | 0 | 1 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 2 | 0 | 2 |
Luciferin 4-monooxygenase | 0 | 0 | 1 | 1 |
Ras guanyl-releasing protein 3 | 0 | 0 | 1 | 1 |
DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
Methionine aminopeptidase 2 | 0 | 1 | 0 | 1 |
Methionine aminopeptidase 1 | 0 | 1 | 1 | 2 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
neurotensin receptor type 1 | 0 | 0 | 1 | 1 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
Alcohol dehydrogenase E chain | 0 | 1 | 0 | 1 |
Alcohol dehydrogenase S chain | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 3 |
Thymidine kinase | 0 | 2 | 0 | 4 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 3 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 4 | 6 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Chain A, Tyrosine-protein kinase | 0 | 1 | 0 | 1 |
Chain A, Tyrosine-protein kinase | 0 | 1 | 0 | 1 |
Chain A, Tyrosine-protein kinase JAK2 | 0 | 1 | 0 | 1 |
Leukotriene C4 synthase | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Sgk1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 25 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase RIO3 | 0 | 0 | 1 | 1 |
Dual specificity mitogen-activated protein kinase kinase 7 | 0 | 1 | 1 | 2 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 1 | 1 |
Peripheral plasma membrane protein CASK | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase DCLK1 | 0 | 0 | 1 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit alpha | 0 | 0 | 1 | 1 |
Muscle, skeletal receptor tyrosine-protein kinase | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 13 | 0 | 1 | 1 | 2 |
Mitogen-activated protein kinase kinase kinase 13 | 0 | 0 | 1 | 1 |
Death-associated protein kinase 3 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
NUAK family SNF1-like kinase 1 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase PAK 3 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 17B | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 14 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase OSR1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Chk2 | 0 | 0 | 1 | 1 |
Proto-oncogene tyrosine-protein kinase ROS | 0 | 0 | 1 | 1 |
Wee1-like protein kinase 2 | 0 | 0 | 1 | 1 |
Uncharacterized serine/threonine-protein kinase SBK3 | 0 | 0 | 1 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 0 | 1 | 1 |
Insulin receptor-related protein | 0 | 0 | 1 | 1 |
Vascular endothelial growth factor receptor 1 | 0 | 0 | 1 | 1 |
Interferon-induced, double-stranded RNA-activated protein kinase | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase MAK | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 11B | 0 | 0 | 1 | 1 |
Fibroblast growth factor receptor 2 | 0 | 0 | 1 | 1 |
Fibroblast growth factor receptor 4 | 0 | 0 | 1 | 1 |
Fibroblast growth factor receptor 3 | 0 | 0 | 1 | 1 |
Activin receptor type-2A | 0 | 0 | 1 | 1 |
Ephrin type-A receptor 3 | 0 | 0 | 1 | 1 |
Ephrin type-A receptor 8 | 0 | 0 | 1 | 1 |
Leukocyte tyrosine kinase receptor | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase receptor UFO | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 4 | 0 | 0 | 1 | 1 |
G protein-coupled receptor kinase 4 | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase receptor Tie-1 | 0 | 0 | 1 | 1 |
Vascular endothelial growth factor receptor 3 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 1 | 2 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0 | 0 | 1 | 1 |
Megakaryocyte-associated tyrosine-protein kinase | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase ZAP-70 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 8 | 0 | 1 | 1 | 2 |
Serine/threonine-protein kinase Nek4 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 12 | 0 | 1 | 1 | 2 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 1 | 1 |
Ephrin type-B receptor 1 | 0 | 0 | 1 | 1 |
Hormonally up-regulated neu tumor-associated kinase | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase SIK1 | 0 | 0 | 1 | 1 |
Receptor-interacting serine/threonine-protein kinase 4 | 0 | 0 | 1 | 1 |
Cell division control protein 2 homolog | 0 | 0 | 1 | 1 |
Calcium-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
Tubulin alpha-1A chain | 0 | 0 | 1 | 1 |
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 0 | 0 | 1 | 1 |
SRSF protein kinase 2 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 9 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase PknB | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase-like 1 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 10 | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase receptor TYRO3 | 0 | 0 | 1 | 1 |
Myotonin-protein kinase | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 12 | 0 | 0 | 1 | 1 |
cGMP-dependent protein kinase 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase PRP4 homolog | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase type 1 | 0 | 0 | 1 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
Ribosomal protein S6 kinase alpha-2 | 0 | 0 | 1 | 1 |
Rhodopsin kinase GRK1 | 0 | 0 | 1 | 1 |
NT-3 growth factor receptor | 0 | 0 | 1 | 1 |
BDNF/NT-3 growth factors receptor | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 6 | 0 | 0 | 1 | 1 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase SBK1 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 19 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase TNNI3K | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase JAK3 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase JAK2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase JAK3 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase Nek5 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 15 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase tousled-like 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 32C | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase pim-3 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase VRK2 | 0 | 0 | 1 | 1 |
Myosin light chain kinase family member 4 | 0 | 0 | 1 | 1 |
Homeodomain-interacting protein kinase 1 | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase type 1D | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase-like 3 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase BRSK2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase NIM1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase ULK2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase DCLK2 | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase kinase 1 | 0 | 0 | 1 | 1 |
Casein kinase I isoform alpha-like | 0 | 0 | 1 | 1 |
Homeodomain-interacting protein kinase 4 | 0 | 0 | 1 | 1 |
Myosin-IIIa | 0 | 0 | 1 | 1 |
Ankyrin repeat and protein kinase domain-containing protein 1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Nek11 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase BRSK1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 35 | 0 | 0 | 1 | 1 |
Rhodopsin kinase GRK7 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 32A | 0 | 0 | 1 | 1 |
Myosin-IIIb | 0 | 0 | 1 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 2 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase-like 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Sgk3 | 0 | 0 | 1 | 1 |
Atypical kinase COQ8B, mitochondrial | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 15 | 0 | 0 | 1 | 1 |
SRSF protein kinase 1 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase RIO1 | 0 | 0 | 1 | 1 |
MAP kinase-interacting serine/threonine-protein kinase 1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase RIO2 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 19 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily M member 6 | 0 | 0 | 1 | 1 |
Testis-specific serine/threonine-protein kinase 1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 33 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase DCLK3 | 0 | 0 | 1 | 1 |
Myosin light chain kinase 2, skeletal/cardiac muscle | 0 | 0 | 1 | 1 |
Homeodomain-interacting protein kinase 2 | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Srms | 0 | 0 | 1 | 1 |
Homeodomain-interacting protein kinase 3 | 0 | 0 | 1 | 1 |
MAP kinase-interacting serine/threonine-protein kinase 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Nek6 | 0 | 0 | 1 | 1 |
SNF-related serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase LATS2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 36 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 32B | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase MARK1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase PAK 5 | 0 | 0 | 1 | 1 |
eIF-2-alpha kinase GCN2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 17A | 0 | 0 | 1 | 1 |
STE20/SPS1-related proline-alanine-rich protein kinase | 0 | 0 | 1 | 1 |
Ephrin type-A receptor 6 | 0 | 0 | 1 | 1 |
Death-associated protein kinase 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase tousled-like 1 | 0 | 0 | 1 | 1 |
SRSF protein kinase 3 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 11A | 0 | 0 | 1 | 1 |
Aurora kinase C | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 0 | 1 | 1 |
Microtubule-associated serine/threonine-protein kinase 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate Reductase | 0 | 0 | 1 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, dihydrofolate reductase (DHFR) | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase type 1 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase type 1 from Tn4003 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
SLC16A10 protein | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Valacyclovir hydrolase | 0 | 0 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
Adenosylhomocysteinase | 0 | 1 | 0 | 1 |
RNA-directed RNA polymerase | 0 | 1 | 1 | 2 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
Platelet-activating factor receptor | 0 | 2 | 0 | 2 |
Cyclin-T1 | 0 | 1 | 0 | 1 |
Pyruvate kinase PKM | 0 | 2 | 0 | 2 |
Cyclin-A2 | 0 | 1 | 0 | 1 |
Cyclin-C | 0 | 1 | 0 | 1 |
Cyclin-H | 0 | 1 | 0 | 1 |
CDK-activating kinase assembly factor MAT1 | 0 | 1 | 0 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 1 | 0 | 1 |
M-phase inducer phosphatase 1 | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 1 | 0 | 0 | 0 | 1 |
twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
Butyrophilin subfamily 3 member A1 | 0 | 0 | 1 | 2 |
Farnesyl diphosphate synthase | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
H | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |